{
  "name" : "dacemirror.sci-hub.se_journal-article_22f3418c5266740a1b093656ab102a18_yang2017.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Nano-Star-Shaped Polymers for Drug Delivery Applications",
    "authors" : [ "Da-Peng Yang", "Ma Nwe Nwe", "Linn Oo", "Gulam Roshan Deen", "Zibiao Li", "Xian Jun Loh" ],
    "emails" : [ "lizb@imre.a-star.edu.sg;", "lohxj@imre.a-star.edu.sg" ],
    "sections" : [ {
      "heading" : null,
      "text" : "REVIEW\n1700410 (1 of 25) © 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nwww.mrc-journal.de\nNano-Star-Shaped Polymers for Drug Delivery Applications\nDa-Peng Yang, Ma Nwe Nwe Linn Oo, Gulam Roshan Deen, Zibiao Li,* and Xian Jun Loh*\nProf. D.-P. Yang College of Chemical Engineering & Materials Science Quanzhou Normal University Quanzhou 362000, China M. N. N. L. Oo School of Chemical and Biomedical Engineering Nanyang Technological University 62 Nanyang Drive Singapore, Singapore 637459, Singapore Prof. G. R. Deen Soft Materials Laboratory Natural Sciences and Science Education National Institute of Education Nanyang Technological University Singapore 637459, Singapore Dr. Z. Li, Prof. X. J. Loh Institute of Materials Research and Engineering (IMRE) A*STAR, 2 Fusionopolis Way, Innovis, #08-03 Singapore 138634, Singapore E-mail: lizb@imre.a-star.edu.sg; lohxj@imre.a-star.edu.sg Prof. X. J. Loh Department of Materials Science and Engineering National University of Singapore 9 Engineering Drive 1, Singapore 117576, Singapore\nDOI: 10.1002/marc.201700410\nheterogeneous star-shaped polymers. Research interest in star-shaped and other forms of polymers has been bolstered by the fact that they are able to self-assemble into supramolecular structures with additional properties that can be designed using their functionalizable arms.[5,6] These unique properties unattainable by their linear counterparts has found many applications in fields from materials science to medicine and pharmaceutics[7]\nWith the unique supramolecular architectures, they possess a combination of many preferential properties in the same system, granting the potential to be used for diverse requirements with a single application.[8,9] The linear branching chains in star-shaped polymers, for example, can be chemically modulated to fabricate stimuli-responsive materials. Stimuli-responsive moieties that are capable of automatically undergoing con-\nformational or chemical changes upon receiving signals from the external environment[10,11] are ideal for applications such as drug delivery where temporal and spatial release of therapeutics are crucial.[12–17] Some typical signals include changes in temperature, irradiation with light, application of mechanical force, exposure to alternating electric or magnetic fields, and changes in chemical composition or pH of the external environment.[18,19] In a parallel manner, recent advances in biomedicine have led to an increased interest toward controlled drug release which can be achieved with these starshaped polymer systems.[20,21] Conventional methods of drug administration are nonspecific and they usually involve periodic application to the patients, raising the concentration of drug levels throughout the entire biological system. This is not ideal as it leads to a transient fluctuation of drug levels within the body. Controlled release of drugs, on the other hand, allows active drugs or chemicals to be released at specific rate and targeted site so as to achieve the intended effect of the drugs.[15,16,22–27] This allows for the convenience of fewer drug administrations, and reduced likelihood of side effects as the dose does not exceed toxic levels. Starshaped polymers, with their functionalizable branch arms can be chemically modified to control the biodegradation rates inside the body, incorporated stimuli-responsive moieties to allow spatial and temporal control for drug delivery, or synthesized with specific biomarkers to target the delivery of these star-shaped drug delivery polymers to the desired physiological environments such as cancer cells.[28,29] It is especially useful in delivering hydrophobic drugs in aqueous environments.[30]\nStar Polymers\nWith the advancement of polymer engineering, complex star-shaped polymer architectures can be synthesized with ease, bringing about a host of unique properties and applications. The polymer arms can be functionalized with different chemical groups to fine-tune the response behavior or be endowed with targeting ligands or stimuli responsive moieties to control its physicochemical behavior and self-organization in solution. Rheological properties of these solutions can be modulated, which also facilitates the control of the diffusion of the drug from these star-based nanocarriers. However, these star-shaped polymers designed for drug delivery are still in a very early stage of development. Due to the sheer diversity of macromolecules that can take on the star architectures and the various combinations of functional groups that can be cross-linked together, there remain many structure–property relationships which have yet to be fully established. This review aims to provide an introductory perspective on the basic synthetic methods of star-shaped polymers, the properties which can be controlled by the unique architecture, and also recent advances in drug delivery applications related to these star candidates."
    }, {
      "heading" : "1. Introduction",
      "text" : "Star-shaped polymers are a class of branched macromolecules with more than three linear arms radiating from a central core.[1–4] When the arms are equivalent in both structure and chain length, they are considered to be homogeneous star-shaped polymers. Otherwise, they are considered to be\nMacromol. Rapid Commun. 2017, 1700410\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (2 of 25)\nPolymer, in general, has been one of the go-to classes of materials to be used as controlled drug delivery vehicles due to its myriad of properties including biocompatibility, the ability to functionalize, and ease of synthesis.[31–35] With newer polymerization techniques developed over the years, we now have improved control over the structures of synthesized macromole cules, especially those of the star-shaped polymers, which has allowed us to functionalize and recombine various arm architectures to suit various needs.[36,37] Star polymers have garnered immense interest for researchers who are looking for more compact and complex architectures with well-defined properties. Star-shaped polymers with more arms meant that they can carry more drug molecules than their linear counterparts and also be functionalized with targeted molecules for more targeted delivery.[38,39] Compact structure also meant that they are not easily removed from blood owing to their smaller hydrodynamic volumes and radii of gyration, strengthening their bioavailability.[40] For such a complex system with abundant desirable properties, much more need to be understood on the current synthesis, properties, and applications to bring the utilization of these star-shaped polymer architectures to the next level.[41] Hence, this review places a focus on the most recent advances in the synthesis and functionalization of starshaped polymers for various drug delivery applications, and provides a contemporary perspective on the innovation in this area that can expedite the development of star-shaped polymers for therapeutic purposes."
    }, {
      "heading" : "2. Star Architectures",
      "text" : "Delving deeper into the study of star-shaped polymers, we note that instead of the simple definition of homogeneous and hetero geneous star-shaped polymers, there are many more complex architectures (Figure 1). This necessitates the need for a more diverse series of classification systems to categorize these star-shaped polymers to comprehensively embrace the unique features that they possess. The section below summarizes some common categories that can be used to describe them in more detail according to their monomer composition, sequence distribution of arms, and chemical or molecular nature of core. However, it has to be noted that these categorization criteria are not exclusive to each other.\nWith reference to Figure 1A, the arms of the star polymers with diblock or triblock copolymers are called star-block copolymers,[2,3,42–44] where the properties of both block copolymers and star-shaped polymers are amalgamated. In functionalized star-shaped polymers or functionalized stars as in Figure 1D, functional groups may be present on the arms, or at the ends of each of the arms. In the former, they are known as in-chain functionalized stars, while in the latter, as end-functionalized star polymers. Molecular weight asymmetry is present in starshaped polymers that possess arms with different molecular weights but identical chemistry. Subdividing the functionalized stars, for functional group asymmetry, the arms are similar chemically, and have equivalent molecular weights, but they possess different functional groups. Whereas in topological asymmetry, the star-shaped polymers’ arms all possess the same chemical composition and molecular weights, but differ\nin terms of which of the polymeric blocks are directly attached to the star-shaped polymer’s core."
    }, {
      "heading" : "3. Synthesis of Star-Shaped Polymers",
      "text" : "The three usual synthetic routes for star-shaped polymers are: the “arm-first”, “core-first”, and the grafting-onto approaches, as presented in Figure 2.[45–47]"
    }, {
      "heading" : "3.1. “Arm-First” Method",
      "text" : "The “arm-first” method is also known as the “arm-in” or convergent approach. This method forms the stars by cross-linking linear arm precursors to first form macromolecular chains, which are then linked to the core via covalent, supramolecular, and coordination bond linking agent that is multifunctional. It has been employed in the synthesis of hyperbranched starshaped poly-l-lactic acid (PLLA) polymers which marry both the fluorescent and bioabsorbable properties.[48] The utility of this method lies in the control it gives over all the synthesis steps, and that by forming the arms first, we can isolate and characterize them. This allows preparation of controlled polymerization with a highly customized control over its structure, composition, and functionality. In this method, the arm polymers can be predesigned and characterized prior to the star\nZibiao Li obtained his Ph.D. in 2014 from the National University of Singapore. Currently, he is working as a research scientist at the Institute of Materials Research and Engineering, A*STAR, Singapore. His research interests are focused on biodegradable and functional polymeric material design, structural property\ninvestigations, and their hybrid fabrications for biomedical and consumer care applications.\nXian Jun Loh is a polymer chemist working in the interdisciplinary field of biomaterials. He is the Programme Manager of the Consumer Care Programme at the Institute of Materials Research and Engineering (IMRE). His main research interests are the design of supramolecular hydrogels for biomedical and personal care applications.\nMacromol. Rapid Commun. 2017, 1700410\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (3 of 25)\nformation, allowing greater control over the exact arm structure required, ideal for synthesizing miktoarm stars. This method also avoids the complication of low molecular weight cores that is further explained in the “core-first” approach later. Another benefit is that the number of branches can easily be assessed by knowing the functionality of the linking agent. These advantages are, however, coupled with the limitation that the arm\nnumber distribution is broader compared to similar architecture produced from other synthesis method, low yield due to low arm to star conversions, and requires rigorous purifications. On an industrial scale, this may make the manufacturing process more complicated, with very narrow margins for error to synthesize well-defined structures.\n3.2. “Core-First” Method\nOther names for this approach are the “armout” or divergent approach. Suitable multifunctional linkers that have the ability to initiate the polymerization of multiple arms, radiating out from the cores, are utilized in this process. A close example being that of Tao et al. where they first synthesized mannitol core linked with poly(d,l-lactide-coglycolide)-d-α-tocopheryl polyethylene glycol 1000 succinate. This novel star architecture with nanoparticle polymer has been reported to have the highest antitumor efficacy, paving the road for future breast cancer chemotherapy.[49] To synthesize well-defined star macromolecules with arms that are similar in molecular weights, the rate of initiation of chain extension must be greater than that of propagation and the different initiation sites must all have a similar degree of reactivity. Most importantly, it gives a high yield of the purest form of synthesized polymer which can be conveniently separated from its starting reagents. However, the linking reaction may be extremely time-consuming, and the products usually tend to have low arm numbers. To circumvent this, many groups have started the synthesis process with functionalized hyperbranched[50,51] and dendritic[52,53] polymers, polysaccharides,[54,55] nanogels,[56] and nanoparticles[57–59] to produce a product with larger core with more arms. Another limitation of this method is that the arms of the synthesized stars cannot be directly characterized, so indirect methods have to be employed to determine the exact characteristics, complicating the synthesis and characterization processes. Furthermore, during the radical polymerization of the arms,"
    }, {
      "heading" : "3.3. Grafting-Onto Approach",
      "text" : "This method allows the most precise structural control among all the star synthesis approaches since the core and the arms can be synthesized separately before forming the final star\nMacromol. Rapid Commun. 2017, 1700410\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (4 of 25)\narchitecture. Usually, this method is used to synthesize stars with low arm numbers (4–8 arms) since a higher arm number makes the process more challenging due to steric hindrance around the core, which can lead to incomplete linking of arms to the core. A hybrid synthesis method of grafting-onto and core-first has been hailed as a useful technique for building miktoarm star polymers,[61–64] where multifunctional cores can first be synthesized and arm polymers can be grafted onto via polymerization."
    }, {
      "heading" : "4. Polymerization Techniques",
      "text" : "About half of the global production of polymers is based upon free-radical polymerization, a proven process that is extremely flexible in its application.[65,66] In free-radical polymerization, the propagating species is the long-chain free radical that is generated by the attack of free radicals from initiators. These unstable initiators make the process very unpredictable and uncontrollable.[67] Hence, living radical polymerization (LRP) was adopted in a bid to circumvent the existing limitations.[68]\nThe usage of LRP is of great convenience as it reduces the need for strict purification of the reactants and allows the utilization and presence of different functional groups during and after the polymerization process.[69] The major techniques of LRP available are atom transfer radical polymerization, reversible addition–fragmentation chain-transfer polymerization, and nitroxide mediated free-radical polymerization.[70–72] The various techniques of LRP have been adopted to grow the arms of the star-shaped polymers. Alternatively, ring opening polymerization (ROP) can also be used to synthesize star-shaped polymers.[73,74] These techniques are described briefly below."
    }, {
      "heading" : "4.1. Atom Transfer Radical Polymerization (ATRP) Technique",
      "text" : "ATRP is an example of a technique used to attain living polymerization, and it functions on the formation of radicals from dormant alkyl halides by halogen abstraction with transition metal complexes.[24,75–83] This method hinges on the fact that the equilibrium in this reaction lies largely on the side of the dormant alkyl halides, meaning that the number of radicals\nMacromol. Rapid Commun. 2017, 1700410\nFigure 2. Synthetic approaches for star-shaped polymers: A) “arm-first”, B) “core-first”, and C) the grafting-onto approach.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (5 of 25)\nproduced is few. This translates into a lower radical concentration, and reduces the possibility of radical termination reactions to maintain the living polymerization of the arms of these star-shaped polymers, or other polymers for that matter.[84,85]\nThe most desirable factor for using ATRP is its ability to prepare well-defined polymers to produce definite polymerization products. Li et al., for example, used ATRP to graft a polyhedral oligomeric silsesquioxane (POSS)-based initiator with block polymers from cationic poly[2-(dimethylamino) ethyl methacrylate] (PDMAEMA) and zwitterionic poly[N-(3-methacryloylamino) propyl)-N,N-dimethyl-N-(3-sulfopropyl) ammonium hydroxide] (PMPDSAH).[86] In this study, the POSS-based octafunctional ATRP initiator was prepared by one step reaction consisting of complex processes of hydrolysis, dehydration, condensation, and structure reforming, which is different from the transesterification reaction reported in previously reported POSS– PDMAEMA star polymers.[87] These star-shaped structures were shown to self-assemble with the POSS hydrophobic core inside, PDMAEMA as the cationic shell, and the PMPDSAH as the hydrophilic nonfouling corona. This amphiphilic hybrid copolymer system was used to codeliver tumor suppressing gene p53 and doxorubicin (DOX) in vivo and showed good drug loading capacity, strong DNA condensation ability, reduced protein adsorption, and good biocompatibility while reducing the side effects. In a similar approach, POSS core and eight disulfide-linked PDMAEMA with different molecular weights were synthesized (Figure 3).[88] In this work, vinyl-POSS was modified to be octasubstituted amine-terminated POSS by click reaction, followed by an arm extension reaction with succinic anhydride to generate eight carboxyl acid groups. The disulfide-containing ATRP initiator was introduced through esterification to obtain the POSS–(SS-Br)8 for subsequent polymerization. Due to the presence of disulfide linkage, this structure is bioreducible into low-molecular weight poly cations with higher transfection efficiency. ATRP has even been used to synthesize star-shaped zwitterionic polymers made of polyamidoamine-graft-poly [3-dimethyl (methacryloyloxyethyl) ammonium propanesulfonate] (PAMAM-g-PDMAPS).[89] To facilitate the ATRP reaction, the second generation PAMAM dendrimers were first prepared and then converted into the PAMAM–Br macroinitiator by the reaction with 2-bromoisobutyryl bromide. Then, dendritic star-shaped polymers PAMAMg-PDMAPS with different PDMAPS chain lengths can be prepared through a typical ATRP process in the presence of zwitterionic DMAPS as monomer. With this system, the drug adriamycin can be loaded not only within the PAMAM core, but also in the PDMAPS layers, which adds additional control over the release profile by adjustment to the PDMAPS chain lengths in addition to its pH-controlled release. Dai et al. have also synthesized biodegradable and biomimetic star-shaped porphyrin core poly(ε-caprolactone)-b-poly(gluconamidoethyl methacrylate) (SPCCL-b-PGAMA) block copolymers by direct ATRP of unprotected d-gluconamidoethyl methacrylate glycomonomer (GAMA) in a three-step reaction.[90] First, the\nMacromol. Rapid Commun. 2017, 1700410\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (6 of 25)\nwell-defined star-shaped polycaprolactone (PCL) with four hydroxyl end groups (SPPCL) was synthesized by the controlled ROP of ε-caprolactone mono mer using porphyrin as initiator. By converting SPPCL precursor into the SPPCL–Br in an terminal acylated reaction with 2-bromo-2-methylpropionate end groups, the subsequent ATRP of GAMA was successfully carried out to produce the designed star-shaped polymers. The resulting polymers display self-assembly and act as nanosized photosensitizing agents which are able to encapsulate hydrophobic drugs for controlled and targeted delivery.\nATRP may be used for both “arm-first” and “core-first” methods, depending on the choice of functional initiators, mono mers, and most critically, the timing and sequence of addition of the comonomers.[91] A caveat is that addition of the cross-linker should only happen strictly before or after polymerization, otherwise, the reaction might result in random branching of polymers or random cross-linking of gel networks.[92] This has been among the most favored approaches used in synthesizing core cross-linked star (CCS) polymers, and its success has been furthered with the creation of an ATRP system where electron transfer is used to regenerate the activators by Matyjaszewski et al., where ATRP can be performed even in conditions with limited air, which makes the fabrication of star polymers more economically attractive.[93]"
    }, {
      "heading" : "4.2. Reversible Addition–Fragmentation Chain-Transfer (RAFT) Polymerization",
      "text" : "RAFT polymerization utilizes chain-transfer agents. It then proceeds by a degenerative transfer process, with the chaintransfer agents being compounds that contain thiocarbonylthio moieties.[2,44,94–97] Among all the LRP techniques mentioned, RAFT polymerization is the most versatile, being able to tolerate a myriad of reaction conditions.[98] Depending on the RAFT agent used, the leaving group may either be bound to the core of the star-shaped polymer, or generate a radical that is\ndetached from the core.[99] Using these methods, we can apply either the “arm-first” or “core-first” approaches described earlier. Since termination cannot be fully eliminated from the LRP processes, this translates into the possibility of radical termination of these species to form unwanted products like star–star coupled products, nonlinear arms, or dead arms. Whereas, in the latter process, the arms of the star-shaped polymer are at all times dormant. This generally means that the products will be cleaner and there will be the absence of the above-mentioned unwanted species.\nIn one study, Zhao and co-workers reported a facile synthesis of star polymers on the basis of S-(4-vinyl)benzyl S′-propyltrithiocarbonate using RAFT copolymerization with vinyl monomers. It showed that the approach based on two successive RAFT processes is general and versatile to synthesize multiarm star polymers with controllable arm length.[100] In a recent report, a new tetrafunctional RAFT agent, tetrabenzyl(1,3-dithietane-2,2,4,4-tetrayl)-tetracarbanotrithioate, was developed to synthesize star-shaped polystyrene (PS) polymers.[101] The Z-group constitutes the core and the R-group is made of benzyl moiety in the designed tetrafunctional RAFT agent, where propagating radicals grow away from the core site and show good ability to control the molecular weight.\nAmphiphilic miktoarm star polymers are especially useful in that they have lower critical micelle concentration as compared to the liner block copolymers, with the added ability to tailor the structure–morphology relationships for various applications by making use of the functionalizable arms. An important aspect of these miktoarm star polymers is that they can also be effectively synthesized by RAFT and further decorated with more features.[102] For example, Qiao and co-workers recently developed a visible light mediated RAFT polymerization technique in the presence of trithiocarbonates (TTC) as the control agent (Figure 4).[103] Interestingly, the “living” core can be further chain extended upon the addition of another fresh monomer to generate additional arms for each stars as well as pseudomiktoarm star polymers. The high retention of TTC groups in\nMacromol. Rapid Commun. 2017, 1700410\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (7 of 25)\nthe star core potentially provides an avenue for postfunctionalization reactions using other coupling chemistries to afford multifunctional nanocarriers for specific applications."
    }, {
      "heading" : "4.3. Nitroxide-Mediated Free-Radical Polymerization (NMRP) Technique",
      "text" : "NMRP utilizes alkoxyamines as the initiators for polymerization.[104–109] These compounds undergo homolysis at the CO bond under certain conditions, producing two radicals, a nitroxide radical and a carbon radical.[110] NMRP then functions on the basis of the persistent radical effect (PRE), observable in some radical systems where the formation of one product is highly favored because of the stability of one of the radical species, nitroxide.[111,112] A critical point to note is that the coupling between these persistent radicals is reversible, hence, the persistent radicals still form a majority even as their concentration increases over an extended period of time. The other radical is transient, and reacts spontaneously with monomers to lengthen the macromolecular chain, or with other transient radicals or the persistent radical to result in a termination step.[113] However, as mentioned earlier, because of the huge availability of the persistent radicals, the transient radicals tend to couple with the persistent radicals rather than with themselves, allowing the polymerization to proceed until the feed depletes.[114] The effectiveness of the polymerization process depends much on the choice of nitroxide species.[110] To achieve rapid chain growth and uniform chain lengths, we will require initiators that enable fast homolysis of the CO bond, with rela tively few side reactions.\nAt any point during the polymerization process, the huge majority of the persistent radicals due to the PRE ensures that the ends of the growing chains are “capped” by the mediating nitroxide.[115] This prevents the termination of arms of the star polymers via the coupling of active chain ends, and affords us greater control over the polymerization process to create arms of equal chain length and structure. In addition, compared to ATRP and RAFT, NMRP possesses many advantages such as the metal free process and is more tolerable to amine and carboxylic acid groups during polymerization. The first report on the synthesis of star-shaped polymers using NMRP can be dated back to 1997 by Solomon and coworkers.[116] Since then, several research groups have reported the preparation of star polymers by NMRP.[117,118] For instance, Kuo and co-workers reported the synthesis of a series of star block copolymers from POSS by core-first NMRP.[119] To facilitate the reaction, eight N-alkoxyamine groups were attached onto the eight corners of POSS cube through quantitative hydrosilylation. The obtained octa-N-alkoxyamines POSS can be used as a platform to further prepare star POSS–(PS)8 homopolymers and POSS–(PS-P4VP)8 diblock copolymers through NMRP, showing narrow distribution in molecular weight control. Recently, Heise and co-workers demon strated the a facile preparation of well-defined polypeptide-based CCS polymers by reaction of 2,2,5-trimethyl-4-phenyl-3-azahexane-3nitroxide-derived alkoxyamine end groups with divinyl benzene (DVB) (Figure 4).[120] In this study, poly(γ-benzyl-l-glutamate-bstyrene) (PBLGA-b-PS) in linear structure was first made from an amine-functionalized alkoxyamine via N-carboxyanhydride (NCA)-ROP followed by chain extension with styrene. A series of CCS polymers were then synthesized through NMRP at different feed ratios (Figure 5). Interestingly, it showed that the conversion efficiency increased at higher content of DVB, probably due to the reduced spatial constraints which could allow for more complete accommodation incorporation of the PBLGA-b-PS into the star structure. Due to the presence of the polypeptide, the yielded nanoparticles from the CCS also demonstrated stimuli-responsiveness at different pH values.[120]"
    }, {
      "heading" : "4.4. ROP Technique",
      "text" : "The ring opening polymerization technique is usually combined with other processes in order to synthesize star-shaped polymers, typically, with arms developed by the living polymerization techniques explained earlier.[121] Miktoarm stars can also be made by incorporating mixed arms during the cross-linking stage.[122] ROP produces stars that are characterized by ester linkages which are desirable biomedical because of the ease of hydrolysis at physiological conditions (Figure 6).[33,123,124] ROP is a two-step one-pot process where ROP is done with the addition of a catalyst and an initiator to produce living arms in a bulk polymerization process. With ROP, higher molecular weight stars can be achieved more quickly, and the stars that are synthesized can be fully degraded, causing them to find huge applications in the biomedical field.[125]\nMacromol. Rapid Commun. 2017, 1700410\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (8 of 25)\nChen et al., for example, have used ROP to synthesize 6-arm star-shaped poly(lactic-co-glycolic acid) (6-s-PLGA) loaded with paclitaxel (PTX) which has been used for antiproliferative therapy.[40] Although PLGA has been long approved by the US Food and Drug Administration, much research is still required to develop previous linear PLGA into different architectures that can effectively meet a wide range of application requirements and this group has demonstrated that this highly stable 6-arm polyplex can be formed using ROP. ROP has also been used to synthesize fluorescent star-shaped polymers from s-poly(methyl methacrylate-co-glycidyl methacrylate) (P(MMA-co-GMA)) by modifying oxirane with ethylenediamine and attaching fluorescein iso-thiocyanate covalently to the amine groups.[127] This system was not only able to induce apoptosis of cancer cells but the fluorescently labeled drug carrier allowed realtime monitoring of the cellular uptake and localization, further improving the drug carrier studies in vivo. Yang et al. has also found that cholic acid, a natural bile acid can be used as a cheap and readily available platform to synthesize branched degradable polymers.[127] In their system, they use ROP to synthesize 3-arm amphiphilic block copolymer from trimethylene carbonate from methyl cholate and conjugated with functionalized poly(ethylene glycol) (PEG) containing vinyl sulfone group which can be used to install biological ligands for better specificity during delivery. This serves as a simpler and cheaper synthesis route using metal-free organocatalytic living ROP which has the potential to be scaled up for mass manufacturing of hydrophobic drug delivery systems."
    }, {
      "heading" : "4.5. Star Polymers Prepared by Combined Techniques",
      "text" : "The combination of different polymerization techniques has also been previously explored to develop star-shaped polymers with complex architectures.[128] In one example, Zhang et al. reported the synthesis of miktoarm star amphiphilic block copolymers poly(styrene)–(poly(N-isopropylacrylamide)-4-vinylpyridine)2 (PS–(PNIPAAM-P4VP)2) via a combination of NMRP and ATRP (Figure 7).[129] In this work, a novel nitroxide free radical, 1-(4-methyleneoxy-2,2,6,6-tetramethylpiperidinoxyl)3,5-bi(bromo-methyl)-2,4,6-trim-ethylbenzene (TEMPO-2Br) was designed and first used to mediate styrene polymerization. Furthermore, the precursor linear PS–TEMPO-2Br was utilized as macroinitiator to prepare the miktoarm amphiphilic copolymers, PS(PNIPAAM)2, by ATRP of NIPAAM.\nThe double hydrophilic miktoarm amphiphilic PS(PNIPAAM-b-P4VP)2 copoly mer was obtained using PS(PNIPAAM)2-2Br as macroinitiator and 4-vinyl pyridine as the monomer via consecutive ATRP chain extension (Figure 7). In addition, the selfassembly behaviors of the resultant miktoarm amphiphilic block copolymers were also investigated. It showed that the aggregate morphology changed from sphere-shaped micelles to a mixture of spheres and rods, and eventually rod-shaped nanorods when the pH value changed from 4.7 to below 1.0.[129]\nIn addition, sequential RAFT and ATRP from a multi-initiator-functionalized hyperbranched polyglycerol (MI-HPG) core were also reported to prepare a mixed arm star copolymers of poly(N,N-dimethylacrylamide) (PDMA) and PNIPAAM.[130] The MI-HPG core was synthesized from an amine-functionalized polyglycerol, followed by modification with 2-chloropropionamide groups (ATRP initiator) and 4,4′-azobis(4-cyanovaleric acid) (azo initiator). By using this initiator, the dimethylacrylamide was polymerized from MI-HPG core by the RAFT method in the presence of S,S′-bis(α,α′dimethyl-α″-acetic acid) trithiocarbonate as a chain-transfer agent. The subsequent controlled synthesis of mixed arm star copolymers was achieved by cografting PNIPAAM onto the HPG-g-PDMA macroinitiator by ATRP.[130] Emerging click chemistry has been demonstrated to be an efficient and fast ligation technology for preparation of star polymers with complex structure and functionalities.[128,131] Satoh and co-workers reported an innovative method to synthesize stereo-miktoarm star poly(lactic acid) (PLA) by click coupling of azido-functionalized poly-d-lactic acids (PDLAs) and the ethynyl-functionalized PLLAs possessing different branches (Figure 8).[132] The parent polymers azido-functionalized PDLAs and ethynyl-functionalized PLLA possessing linear and two- and three-branched structures were prepared by the ROP of d-lactide and l-lactide using azido- or ethynyl-functionalized initiators. The click reaction of the azido-functionalized PDLAs and the ethynyl-functionalized PLLAs using the copper(I) bromide/N,N,N′,N″,N″pentamethyldiethylenetriamine catalyst afforded 3-, 4-, 5-, and 6-armed stereo-miktoarm star-shaped PLAs. The unique structure allowed these stereo-miktoarm star-shaped PLAs formed stereocomplex crystals without any trace of homochiral crystallization.[132]"
    }, {
      "heading" : "5. Properties of Star-Shaped Polymers",
      "text" : ""
    }, {
      "heading" : "5.1. Bulk Properties",
      "text" : "Any polymers which have multiple domains, or with multi ple blocks or are made from multiple components generally have the ability to generate controlled or well-defined multi phase morphologies. These could go through order–disorder transitions and order–order transitions to result in other morphologies which may be utilized for specialized applications. As investigated by Olvera de la Cruz and Sanchez, the static structure factor can be represented functionally as χ=    − −( ) ( ) 21S q Q q N ,\nMacromol. Rapid Commun. 2017, 1700410\nFigure 6. The use of ROP in synthesizing star-shaped polymers. Reproduced with permission.[126] Copyright 2003, American Chemical Society.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (9 of 25)\nwhere Q is a copolymer-dependent function, N refers to the number of repeat units in each polymeric chain, and χ refers to the Flory interaction parameter. From the spinodal curves they plotted, they managed to determine that it is easier for linear diblock copolymers to phase separate as compared to symmetrically grafted A2B miktoarm star-shaped polymers. They\nMacromol. Rapid Commun. 2017, 1700410\nFigure 7. Synthesis of miktoarm star amphiphilic block copolymers poly(styrene)–(poly(N-isopropylacrylamide)-4-vinylpyridine)2 (PS–(PNIPAAMP4VP)2) via a combination of NMRP and ATRP. Reproduced with permission.[130] Copyright 2009, John Wiley and Sons.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (10 of 25)\nalso concluded that for nearly symmetrical AnBn miktoarm star-shaped polymers, microphase separation was solely influenced by the molecular weight of the diblock copolymer, instead of the molecular weight of the whole star.[133]"
    }, {
      "heading" : "5.2. Properties and Rheological Behavior in Solution",
      "text" : "The thermodynamics and kinetics of micellization, and the micellar structural parameters – namely aggregation number, micellar size, dimensions of the core and the shell, and critical micelle concentration (CMC) have been studied extensively in the past (Figure 9).[134] In general, polymer or macromolecule architecture plays a key role in manipulating micellar properties, and provides a new avenue for tuning micelle behavior for specific applications.[135–137] In the recent past, a few studies dealt directly with the complex star-shaped architectures, and the major takeaway is that star-shaped polymers tend to show reduced aggregation numbers with larger CMC values than similar polymers taking up the linear form.[102] However, the CMC values between star polymers and linear polymers also varied when the factors are different, such as the molecule weight, topological structure, chain length, etc.\nPolymeric micelles are also able to provide sustained release of the entrapped drugs over periods ranging from hours to days in most cases. In these, the drugs are released from the micelle core via outward drug diffusion, or through the disintegration of the micelle. If the glass transition temperatures of the components forming the core are above the average body temperature of 37 °C, these cores are in the glassy or frozen state, and they cause a slower rate of drug release. Also, the strength of the interaction between the drugs and the segments forming up the core can influence the rate at which outward diffusion of the drug occurs. It is also worthy to note that the amount of drug loaded can also take on a determining role in the drug release rates. When the drug loading of hydrophobic drugs like clonazepam is too high, there is a great likelihood of drug crystallization within the core of the micelle, which reduces the drug release rates. In general, given the aggressive environment in\nthe body, most designs are structured toward attaining slower drug release rates for efficient and targeted drug delivery.\nOver the years, the most studied classes of soft materials are linear polymers and colloids, and they differ significantly in terms of dynamics and rheological behavior. Linear polymers tend to be involved in short range interaction, which in turn means that high concentrations are required for them to attain ordering in solutions. Conversely, colloidal solutions display strong long range interactions and ordering in the solution phase. Both these structures represent nagging extremes of behaviors in solution, and complex macromolecular structures like the star-shaped polymers are the means to achieve something in between. Like typical micellar structures of diblock copolymers, star-shaped polymers show a nonuniform mono mer density distribution. Star-shaped polymers that are dissolved in good solvents at concentrations higher than the coil overlap concentration – where steric and frictional interactions with neighboring coils are nonnegligible,[138] exhibit liquid-like order. This is a consequence of the augmented osmotic pressure that compensates for the stored deformation energy of the outstretched arms (because of entropic gain) of the star. Above the coil overlap concentration, cooperative diffusion, self-diffusion, and structure relaxation controlled density fluctuations and the relaxation of concentration.\nIn general, star-shaped polymers often differ in terms of thermal properties as compared to similar polymers with the linear form because of their complex molecular architecture, and they usually possess lower glass transition temperatures, melting points, crystallinities, and decomposition temperatures versus their linear counterparts, as is the case for star-shaped versus linear polylactides.[139] These properties are, however, heavily dependent on the type and number of the end or terminal groups.[140]"
    }, {
      "heading" : "5.3. Viscoelastic Properties of Star-Shaped Polymers",
      "text" : "Person and Helfand put forth a theory in 1983 describing the viscoelastic properties of star polymers, by predicting how the viscosity, μ0, and the steady-state shear compliance, e0J , depend on molecular weights. Included was also how the dynamic moduli, G′(ω) and G′′(ω), depended on frequency. This is based on star-shaped polymers having f number of arms. The relations are as follows\nµ ∝    \n′    exp0 a\ne\n1 2\na\ne\nM M v M M\n(1)\nwhere Ma is the molecular weight of the arm, Me is the molecular weight between entanglements and v′ is a constant associated with the potential function, and\n∫ ∫( ) ( )= \n \n  \n∞ ∞\nd / de 0\n0 0\n2\nJ tG t t G t t\n(2)\nwhere G(t) is the stress relaxation modulus, and\nMacromol. Rapid Commun. 2017, 1700410\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (11 of 25)\n* ( ) ( ) ( ), with 10 1G G iG G t G t Oω ω ω ξ α( )( )( ) ( )≡ ′ + ″ = − + − (3)\nwhere Fourier transform of the stress relaxation modulus allows us to obtain the dynamic modulus, with ξ(t) being the fraction of the tube that has undergone relaxation due to the movement of the end of the an arm passing through. These equations were developed based on the theory of concentrated solutions of linear polymers.[141]\nPolymer materials with highly elastic mechanical properties are especially important for bone tissue regeneration and drug delivery applications because they match the innate elastic and ductile properties of many tissues in the body, making them an ideal drug delivery medium. Hence, Xie et al. has developed a biocompatible and elastomeric star-shaped polymer via photocrosslinking from inositol-based PLLA and PEG.[142] They have proven this the star-shaped polymer showed desirable elasticity of 18 MPa in tensile strength, 200 MPa in modulus, and 200% in elongation, which are all comparable to the values of most human tissues."
    }, {
      "heading" : "5.4. Self-Assembly Behavior in Solution",
      "text" : "The self-assembling of star-shaped polymers in solution can be enabled by attaching functional groups along or at the end of the star’s arms for homogeneous stars, or by using selective solvents for miktoarm and star–block copolymers. These will cause the star-shaped polymers to form micellar structures in solution, and in this state, they can be utilized for numerous applications. An example of stimuli-responsive self-assembly in solutions is evident in the miktoarm stars synthesized by Ge et al., comprising a temperature responsive PNIPAAM arm and four pH-sensitive PDMAEMA arms.[143] These stars self-assembled into micellar structures with PNIPAAM and PDMAEMA cores in acidic environments (at elevated temperatures) and slightly alkaline environments, respectively.\nRecently, Tsukruk and co-workers reported a complexed hierarchical self-assembly of vesicle formation from a cationic miktoarm star polymer, poly(ethylene oxide)113-(quaternized poly(2-(dimethylamino)ethyl methacrylate)60)4 and a linear anionic polyelectrolyte, (poly(styrenesulfonate)20) through electrostatic interactions (Figure 10).[9] Due to the presence of bis-hydrophilic phase from cationic miktoarm star polymer and linear anionic polymer, the resultant vesicles possessed unilamellar formation, with inter-polyelectrolyte complexe wall sandwiched between poly(ethylene oxide) brushes, as illustrated in Figure 10A. The obtained vesicles can be further used to fabricate microcapsules with tannic acid via facile layerby-layer (LBL) assembly (Figure 10B). The hydrogen bonding between tannic acid (TA) and polymersomes provided the main driving force for the LBL self-assembly which is highly sensitive to external pH. Through the combination of the star polymer based vesicles and LBL with TA, a dual-responsive behavior with the programmable release of two different types of encapsulated molecules from the multicompartmental microcapsules was obtained (Figure 10C), showing vast potential applications in self-healing materials, smart coatings, and microreactors.[9]\nIn addition to the micelle and vesicle, the self-assembly of star polymers to form intelligent hydrogel formation has also been widely exploited.[144] In one recent study, Li et al developed a novel star–star supramolecular hydrogel from the selfassembly between a star-shaped adamantyl-terminated 8-arm poly(ethylene glycol) and a star-shaped poly(N-isopropylacrylamide) with a β-cyclodextrin (β-CD) core (Figure 11).[145] The strong ability to form inclusion complexation between the two parent star polymers would subsequently self-aggregate into a 3D network that induced thermoresponsive hydrogel formation. The star–star supramolecular architecture was formed via self-assembling host–guest interaction, in which the starshaped PNIPAAM with one β-CD core is the macromolecular host, and the adamantyl-terminated 8-arm PEG star polymer is the macromolecular guest. At low temperature of 25 °C, the star–star pseudo-block copolymer dissolved in water to form clear solution and this host–guest mixture transited into a white stable hydrogel when the temperature increased to 37 °C. Interestingly, this sol–gel transition was completely thermoreversible, making it unique and different from the previously reported irreversible supramolecular gel-forming system.[146]"
    }, {
      "heading" : "5.5. Drug Encapsulation Properties",
      "text" : "Amphiphilc star polymers with their hydrophobic cores are especially useful in encapsulating hydrophobic drugs to deliver into aqueous in vivo environments, which otherwise would be unachievable with free drug delivery alone.[147] There are two primary methods for encapsulating hydrophobic drugs in micelles of star polymers, or micelles of any other polymers for that matter; the dialysis and the oil in water (o/w) emulsion methods. In the first method, the drug and the star-shaped polymers are simultaneously dissolved in a good solvent following which they are to be dialyzed against selective solvents. In this dialysis process, the micelles begin to form, and as they do, they simultaneously incorporate the drugs into their micelle cores. Conversely, in the o/w emulsion method, the drugs are first dissolved into a suitable organic solvent (take, for instance, dichloromethane), and they are then added to a solution of micelles in the aqueous condition dropwise. The (hydrophobic) cores of these micelles would then trap the emulsion containing the drug, thus the drug gets incorporated into the micelle core as the organic solvent is evaporated. The structure of the macromolecule involved can greatly affect the drug carrying ability of the polymeric micelles, and is a core factor influencing the stability, size, size distributions, kinetics of release, and the biodistribution of the micelles. In star-shaped polymers with hydrophobic cores, the cores serve as a nanosized reservoir for the storage of the drugs. Thus, the composition of the core blocks can influence the efficacy of drug loading and drug release behaviors.[148] It also has to be noted that the compatibility between the drugs to be loaded and the micelle core-forming blocks is one of the crucial factors that should be accounted for when designing the star-shaped polymers. The biodegradability of the core segments also has to be considered, to ensure that there is no accumulation of drug carriers in the body that remain there for the long term. Knop et al. have demonstrated the fabrication of unimolecular micelles\nMacromol. Rapid Commun. 2017, 1700410\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (12 of 25)\nfrom amphiphilic star-shaped [PCL18-b-POEGMA]4 and [PCL18b-poly(oligo(2-ethyl-2-oxazoline)methacrylate)s (POEtOxMA)]4 which showed greater stability of the DOX-encapsulating hydrophobic core than free drug in aqueous environments with no short term cytotoxicity.[149] The presence of both hydrophobic and hydrophilic parts in amphiphilic stars not only acts as a driving force to self-assemble in water, but also encapsulates a poorly soluble molecule, proving its worth as a drug nanocarrier. This can be accomplished by synthesizing star-shaped polymers that contain poly(tert-butyl acrylate) arms which were subsequently deprotected to produce hydrophilic poly(acrylic acid) (PAA) arms.[150] Alonso-Cristobal et al. have also achieved similar results by using branched poly(ε-caprolactone) as hydrophobic core and branched PEG as the hydrophilic arms.[151]\nRecently, star-shaped polymers with CD core and cationic arms have also raised much interest in drug delivery research as they can coload both hydrophobic drugs and genes from stable polymer complexes in vivo, without much trouble with micellization requirements.[152] This system has been successful in\nin vitro gene transfection to MCF-7 breast cancer cells[153] and docetaxel (DOC) and siRNA target plasmid MMP-9 (pMR3) to HNE-1 cells.[152]"
    }, {
      "heading" : "6. Functionalization of Star-Shaped Polymers",
      "text" : "Another important aspect of star-shaped polymers is the ability to functionalize them well with the different polymerization methods that have been developed. Using special functional groups, we can allow for drugs to achieve more targeted deliveries, for drugs to be imaged, for incorporating other biocompatible functionalities, and for dealing with solvent incompatibility issues. To elaborate more on targeting functionalities, by attaching specific ligands that can recognize cancerous cells or tumors (or any other disease-related physiological sites), one can significantly increase the efficacy of drug delivery systems. Closely related to this is the imaging functionality where attached functional groups may allow\nMacromol. Rapid Commun. 2017, 1700410\nFigure 10. A) Self-assembly of vesicle formation from a cationic miktoarm star polymer and anionic linear polyelectrolytes. B) Scheme illustration showing the LBL assembly process of microcapsules from vesicles and tannic acid. C) Demonstration of the sequential release of two types of molecules from the as-fabricated microcapsules. Reproduced with permission.[9] Copyright 2016, American Chemical Society.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (13 of 25)\nmedical practitioners to identify diseased tissues that the stars have latched on to. Moreover, biocompatible functionalities like lengthening the duration of which a particular drug circulates in the body can be made possible through incorporating certain functional groups. To this end, surface functionalizing star-shaped polymers with PEG has seemingly achieved success, allowing a “passive targeting” of tumors by virtue of having the drug circulate for longer periods within the body.[154] This is described as the “enhanced permeability and retention” effect.[155] Disulfide groups can be degraded to thiol groups in the presence of a variety of reducing agents. In previous study, Matyjaszewski and co-workers reported the synthesis of thiol-/ disulfide-functionalized star polymers and their redox response behavior (Figure 12).[156] In their report, a poly(n-butyl acrylate)based star polymer, poly(ethylene glycol diacrylate)-poly(nbutyl acrylate) (polyEGDA–(polyBA)n), was first synthesized by ATRP, followed by a further polymerization of a disulfide (SS) cross-linking agent bis(2-methacryloyloxyethyl) disulfide to from the arm end SS cross-linked star polymer. It showed that the\nMacromol. Rapid Commun. 2017, 1700410\nFigure 11. Formation of the star–star supramolecular architecture induced by the self-assembly of star-shaped polymers and the temperature induced supramolecular hydrogel formation. Reproduced with permission.[146] Copyright 2013, Wiley-VCH Verlag GmbH & Co. KGaA.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (14 of 25)\ndisulfide functionality could be cleaved via reducing reactions, generating individual stars containing SH groups at the chain ends. Interestingly, the transformation between SS cross-linked star and SH-star was reversible via repetitive reduction and oxidation. As a consequence of this reversible reaction, disulfide cross-linked star polymer gels were also obtained. Dynamic mechanical study showed that SS-functionalized star polymers respond to reduction–oxidation conditions, indicating the cleavage and the reformation of the disulfide bonds, indicating high potential of utilizing this intelligent polymeric materials in self-healing applications.[156]\nIn addition to functionalizing star polymers by organic compound, utilization of inorganic nanoparticles to tune the material features star polymer has also been explored. Liu and co-workers recently reported the functionalization of Au nanoparticles onto the surface of thiol-functionalized H40-PNIPAAM star polymers in a two-step reaction in aqueous solution (Figure 13).[157] Thermoresponse H40-PNIPAAM star polymers were first prepared by modification of H40 dendrimer into H40-based macroRAFT agent, followed by the poly merization of NIPAAM monomer in a typical RAFT process. In aqueous solution, H40-PNIPAAM star polymer dissolved and selfassembled into unimolecular micelles with H40 as the core with surrounding PNIPAAM grafts as the corona. The dithioester groups conjugated at the surface of unimolecular micelles could be transformed to thiol groups upon addition of excess sodium borohydride (NaBH4). The gold nanoparticle decorated hybrid star polymers were obtained after addition of the thiol-terminated H40-PNIPAAM into the citrate-capped gold nanoparticle solutions. Due to the covalent linkage between surface thiol groups and gold nanoparticles, the obtained hybrid system is extremely stable, and exhibi ted reversible swelling and shrinkage in response to external temperatures. The\nshrinkage of PNIPAAM corona would concomitantly decrease the average distance between gold nanoparticles on the micelle surfaces. This would further induce a dramatic redshift of the maximum of the surface plasmon band from 524 to 535 nm by the enhanced interparticle coupling effect.[158]\nThe uniqueness of star-shaped polymers is the fact that it is possible to achieve a high local density of active functional groups which can be modulated according to various requirements. Various stimuli-responsive moieties such as pH responsive DMAEMA and temperature responsive NIPAAM can now be linked onto the drug encapsulating cores such that the release profile can be externally controlled precisely. This opens up the window to many potential applications, namely advanced coatings, nanostructured thin films, and drug delivery.[159] More details on this controlled delivery will be discussed in the next section."
    }, {
      "heading" : "7. Applications of Star-Shaped Polymers",
      "text" : ""
    }, {
      "heading" : "7.1. Star-Shaped Polymers for Use in Drug Delivery",
      "text" : "In this review, we are mainly focused on using star-shaped polymers for drug delivery. In this regard, amphiphilic starshaped polymers seem to be the prominent candidate owing to their abilities to encapsulate and contain molecules. There are several reports on using star polymers for drug delivery. For instance, the usage of star-shaped polymers with PS or poly(nbutyl acrylate) hydrophobic cores as initiators in the polymerization of cationic DMAEMA. Here, the star polymer existed in the glassy state, resulting in reduced DNA transfection as compared to when rubbery polymers were utilized.[160] Traditional methods of polymeric drug delivery simply encapsu-\nMacromol. Rapid Commun. 2017, 1700410\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (15 of 25)\nlates drugs to the hydrophobic cores, but this is often plagued by problems of early release or poor delivery as the micelles may start to degrade and unload the drugs before reaching their targets.[35,158,161–167] This method is also usually characterized by low drug loading capacities. To deal with this problem, newer methods involve the conjugation of drugs to the poly mer chains through covalent chemical bonding. This leads to improvements in both drug loading capacities and it also affords better control over the release profiles of the drug.[168] Also, for cancer drug delivery, where the optimum size for accumulation at tumor sites is in the range of tens of nanometers, Liu et al. polymerized monodisperse poly(oligoethylene glycol) methyl ether acrylate (POEGMA) based stars via RAFT. Aldehyde groups at the core of the stars were utilized for the attachment of doxorubicin – a bacterial antibiotic used primarily in the treatment of leukemia and other forms of cancer. The in vitro studies showed that the stars with attached doxorubicin had similar levels of cell toxicity as compared to free doxorubicin,[169] and this presents a method of cancer treatment that might serve as a more targeted approach in drug delivery.\nIn a similar manner, Wei et al. managed to synthesize a star block copolymer with four arms, comprising, on average, a single hydrophobic poly(methyl methacrylate) (PMMA) arm, with three hydrophilic PNIPAAM arms.[170] This required careful design and molecular level synthesis. The carboxylic acid-functionalized PMMA (PMMA-COOH) were first prepared via radical polymerization with 3-mercaptopropionic acid as the chain-transfer agent, while PNIPAAM blocks were prepared by making amino-terminated PNIPAAM (PNIPAAM-NH2) via radical polymerization with 2-amino ethanethiol hydrochloride being used as the chain-transfer agent. The functionalized PNIPAAM-NH2 was attached to longer PNIPAAM macromers via a condensation polymerization method involving the amino groups of PNIPAAM and N-acroyloxysuccinimide. These were extended by attaching to larger PNIPAAM blocks, and were eventually connected to the PMMA block to produce the star-shaped polymer. The star-shaped block copolymers were amphiphilic in nature, and they underwent self-assembly to form micelles in aqueous environments, into spherically shaped nanoparticles. By measuring the optical absorbance of the samples, it was determined that the micelles formed were able to show reversible aggregation and dispersion in response to the thermal cycles they were exposed to. This was due to the fact that the outer polymer layer, which mainly comprised PNIPAAM, had a lower critical solution temperature (LCST) of 34 °C. This star-shaped polymer was able to exhibit good entrapment efficiency of prednisone acetate due to its unique structure, and it also had good drug release behavior.[170] In the latter, it aims to achieve high densities or concentrations of the ethylene glycol chains, and yet at the same time, we wish to remove the tendency of the dilution of ethylene glycol following injection. Both of this can be achieved simultaneously with the adoption of a star-shaped polymer architecture. Ooya et al. successfully improved PTX solubility in water by about four orders with the synthesis of star and dendrimer architectures of ethylene glycol units.[171] Dendrimers of polyglycerol (dendriPGs) were miscible and soluble in water at high concentrations, with no sizable effect on raising the viscosity of the resulting solution. Moreover, at 80 wt%, dendriPGs improve the solubility of\nPTX by 10 000-fold. Following this, solubilized PTX could then be unloaded into the body from the dendriPGs – this was also tested with the star-shaped graft polymers in an aqueous environment. The release rates were determined to be a function of the star and dendrimer generation.[171] This new architecture utilizing the star-shaped polymer structure signals the potential introduction of new methods of drug delivery in the future, especially in the case of drugs with low water solubility.\nInstead of using PEG as the hydrophilic segments, Cheng et al. developed 4-arm star block copolymers (with biodegradability) using poly(ethyl ethylene phosphate) (PEEP) as the hydrophilic shell instead. This was done by ROP of 2-ethoxy2-oxo-1,3,2-dioxaphospholane with hydroxyl terminated four arm star poly(ɛ-caprolactone) with stannous octoate (Sn(Oct)2) as a coinitiator. These stars had low CMC values in the range of 5.74 × 10−4 to 3.87 × 10−3 g L−1, and they spontaneously assembled into micelles with sizes ranging from 45 to 110 nm. They were also shown to load between 1.6% and 3.5% (wt/wt) of PTX with drug loading efficiencies of 16–35% that were roughly two times higher than their linear counterparts. The drug release observed showed a spike at the initial phase, following a stabilization of the release rate with a sustained release of up to two weeks (slower rate as compared to linear counterparts), with an eventual release 45–85% of the initially loaded PTX in the 25 d test duration. It was also shown that polymer structure correlates significantly to the drug release kinetics, with faster release with an increasing fraction of PEEP, and conversely slower release rates were obtained with longer hydrophobic blocks. Finally, in vitro cytotoxicity assays were ran, which exhibited the biocompatibility of these star-shaped block copolymers comprising PEEP and PCL as they showed no apparent cytotoxicity.[172] Also, another example of an approach to improve the solubility of hydrophobic drugs are the star-shaped polymers synthesized by Deng et al. with poly(amidoamine) (PAMAM) dendron arms and β-CD cores. These stars were cationic under the correct conditions, and they proved to be good buffering agents, possess good small interfering RNA (siRNA) loading capabilities, had high siRNA transfection efficiencies in fibroblasts, and also showed good biocompatibility with low cytotoxicity. The structure of the core also meant that it possessed vacant internal hydrophobic cavities which could be used to encapsulate poorly water soluble drugs.[146] To test this, methotrexate (MTX), which is well-known to be poorly soluble in aqueous conditions, was used to be loaded into one of the variants of these stars via the dialysis method. The dendron arms played a vital role in helping achieve sustained release, by hindering the outward diffusion of the entrapped MTX. Thus, these stars could see potential multifunctional applications in drug delivery as well as efficient siRNA delivery.[173]"
    }, {
      "heading" : "7.2. Controlled Drug Release Using Star-Shaped Polymers",
      "text" : "In recent times, the self-assembly of micelles from amphiphilic copolymers for the delivery of drugs has risen in popularity.[174] Further improvements to these delivery systems in recent years include equipping them with the ability to respond to external signals, for instance, a change in pH or temperature. These bestow the micelles with controlled drug release abilities. The\nMacromol. Rapid Commun. 2017, 1700410\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (16 of 25)\nrelease kinetics of drugs is arguably the most critical aspect of drug delivery systems that needs to be discussed. The architecture of the star-shaped macromolecules significantly affects the rate at which encapsulated molecules and drugs diffuse out of their cores, in addition to the other major factors – core to shell size ratios, polymer hydrodynamic volumes, degree of amphiphilicity, and density of arms. Another way of influencing drug release is to functionalize the drugs with stimuli-responsive behavior. One example of this is to incorporate pH-sensitive degradation to stars, which may allow targeted drug release as the body comprises many different environments with different localized pH values. Degradation of these star-shaped polymers is also critical in any biomedical applications as we should always try to reduce the accumulation of polymeric materials in the body as much as possible, by allowing them to degrade into smaller or metabolizable fragments.\nAs emphasized earlier, the two critical components of starshaped polymers are the cores and the arms, and these have different degradation behaviors. With the methods explained above, we can potentially attach cores with arms of virtually any chemical composition to design the desirable physical properties. For example, it has been reported that higher branching resulted in faster degradation rate.[175] Also, as water is present in huge amounts in the body, hydrolysis is typically looked at as one of the ways to degrade the arms, and this explains why polyester-based structures are typically utilized in the arms of CCS polymers. For instance, similar to PLA, PCL is also generally considered to be a biocompatible and biodegradable (although it takes some time) polymer[31,137,174,176,177] and this is incorporated into the arms of star-shaped polymers by using alkyl halide functionalized PCL chains in the synthesis process. These are then cross-linked to the core with monomeric divinyl species such as DVB so that the arms can be easily removed by hydrolysis, without disturbing the functionality of the star’s core (Figure 14).[178] In miktoarm star polymers, one can design stars with only a fraction of degradable arms, allowing us greater control over the rate at which the drug is being released as the density of the stars’ coronas influence how easily drugs can diffuse out of the cores. In this respect, stars with more degradable arms typically show increased drug release kinetics as compared to their counterparts with a smaller ratio of degradable arms.\nAs opposed to influencing the rates of diffusion, by tweaking the degradability of the cores, we can have a more direct effect\non the drug release kinetics as once the cores degrade, all the encapsulated drug molecules are dispersed instantly. Some examples involve the inclusion of acid degradable ester linkages within the core,[179] the usage of acid-labile di(methacryloyloxy1-ethoxy)methane cross-linker to obtain cores that can degrade,[180] the incorporation of cleavable disulfide linkages (which unfortunately produces stars with broad polydispersities using ATRP),[181] or the usage of bislactone cross-linkers to make polyester-based cores.[178]\nIn another approach, a semi-interpenetrating network consisting of poly(vinyl alcohol) (PVA) and star PDMAEMA was used as a drug delivery vehicle. This method of drug delivery represents a departure from the drug delivery methods that have been discussed thus far. This semi-interpenetrating hydrogel network was able to swell in aqueous conditions, and developed a porous structure after treatment in acid by virtue of the presence of the star PDMAEMAs. These pores and the swollen structure provided greater volume and exposed surface area for drug storage, and also numerous other avenues for the release of drugs. Under different pH conditions, these composite hydrogels comprising star PDMAEMAs exhibited different drug release behaviors. These stars take on more extended conformations at lower pH, creating more pores, resulting in quicker drug release.[182] The section below will detail the different forms of external stimuli that can be employed for a wide variety of drug delivery applications."
    }, {
      "heading" : "7.2.1. Thermoresponsive Star-Shaped Polymers",
      "text" : "The first example of thermoresponsive stars is the thermoresponsive core–shell nanoparticles from miktoarm stars comprising hydrophobic PS, PCL, and PNIPAAM synthesized by Zhang et al.[183] These stars then form micelles through self-assembly in aqueous environments with PS and PCL at their cores, and a corona comprising PNIPAAM. Upon hitting the PINIPAAM segment’s LCST, the micelles shrink spontaneously in response to the temperature change. By altering the amount of PNIPAAM in these stars, the nanoparticle size can be controlled.[183] Chen et al. utilized thermosensitive PNIPAAM and PCL blocks as arm segments for fabricating thermoresponsive star-shaped copolymers that were able to form micelles for drug delivery. These were synthesized by ROP of ε-caprolactone with cholic acid functionalized PNIPAAM macro initiators, and the resulting stars had an LCST of 37 °C, and cytotoxicity tests revealed no obvious cytotoxicity. These stars undergo self-assembly into spherical micelles at room temperature in aqueous environments with relatively low CMCs, and they had diameters ranging between 30 and 75 nm. The drug loading ability of the stars was tested with MTX, an anticancer drug, with which they exhibited effective loading and a temperature triggered drug release rate. This was possible due to the temperature-sensitive micelles which could undergo phase transitions that corresponded with significant thermosensitive size changes at different temperatures.[184] In another type of thermosensitive star polymers, Zhang et al. have used β-CD as a core for drug encapsulation with hydrophilic PDMA blocks and temperature-responsive PNIPAAM blocks.[185] Below the LCST,\nMacromol. Rapid Commun. 2017, 1700410\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (17 of 25)\nboth blocks are water soluble but above the LCST, PNIPAAM blocks become insoluble aggregates. These aggregations interact together with the hydrophilic blocks to form a 3D hydrogel which has unique properties of biocompatibility, convenient gel formation, and thermal responsibility as a potential drug delivery medium."
    }, {
      "heading" : "7.2.2. pH-Responsive Star-Shaped Polymers",
      "text" : "Schramm et al. synthesized water soluble star-shaped polymers with PCL and various methoxy polyethyleneglycol methacrylate monomers (Figure 15).[186] These produced stars with biodegradable hydrophobic cores which can release the encapsulated drugs or molecules under acidic conditions.[186]\nIn another study in 2009, Kul et al. synthesized star-shaped block polymers with 5 poly(t-butyl acrylate) arms attached to a poly(ethylene oxide) core via ATRP to use as unimolecular nanocontainers. The arms were hydrophobic and the core was hydrophilic. In acidic media, the t-butyl acrylate groups hydrolyzed to form acrylic acids for the unloading of the encapsulated drugs.[187] Another interesting use of pH-responsive star-shaped polymers involves the development of a hydrogel for drug delivery from an interpenetrating network of poly[2(dimethylamino)ethyl methacrylate] stars of 21 arms and PVA by Wu et al. which will be further elaborated in a following section.[182] Connal et al. prepared PAA-based core CSS by using acid-protected poly(tert-butyl acrylate) via ATRP, and reacting it with divinyl benzene before deprotection.[188] These PAA star polyelectrolytes had fully charged acrylic acid groups in the pH range of 8–10, and they adopted a more “open” conformation with larger diameters (about 30 nm). At lower pH, protonating the acrylic acid groups cause the polymers to return to a more coiled conformation, with smaller diameters in the region of 23 nm. In this study, pH-responsive multilayer films were developed from these PAA-based core stars and poly(allylamine hydrochloride) (PAH). These films could be utilized for biomedical applications, and in drug delivery, where each of the individual CCS polymers that are coated onto the thin film may serve as a nanocontainer for drug loading and release (Figure 16).[188]\nAnother example of pH-responsive nanofilms developed from star-shaped polymers can be seen in the work of Kim et al., where PDMAEMA stars and PAA star-shaped polymers are both incorporated into thin films with multiple layers via a LBL assembly.[189] This was executed by using the electrostatic interactions between the polyelectrolyte arms of these stars. Because of the unique structure of star-shaped polymers, the films that were made were nonuniform and nanoporous, however, the thickness and porosity of the multilayer star films could be tuned by adjusting the pH during assembly. During post-treatment, different pH environments would result in extensive structural change in the films, which was not possible with their linear counterparts. The pH responsive behavior of these nanofilms opens up many potential applications in their use as drug delivery vehicles.[189]\nJones et al. prepared pH-sensitive star-shaped polymers with ethyl methacrylate and tert-butyl methacrylate to make up the hydrophobic segments, and poly(ethylene glycol)methacrylate for the hydrophilic segment. They form unimolecular micelles that may be used to encapsulate drugs. The greater the amount of hydrophobic monomers, the higher the molecular weights of the aggregates they formed in water. Upon hydrolysis, the tert-butyl methacrylate groups introduced acid functions, and the stars exhibited two main sizes at both low and high pH. By increasing pH, more of the acid functions along the arms will get ionized, and this is associated with an increased progesterone in vitro release rate.[190]\nIn a similar manner, Lidicky et al. have proposed the use of star-shaped polymer–doxorubicin conjugates synthesized as long-circulating high molecular weight polymer prodrugs with a dendrimer core and target-specific antibody attached at a single point to form star architecture.[191] The anticancer drug doxorubicin encapsulated in this system was attached to the N-(2-hydroxypropyl)methacrylamide (HPMA)-based copolymer chain via a pH-labile hydrazone linkage. This make the system stable at pH 7.4 but the drug was readily released in pH5-5.5 acidic environments via the hydrolysis of the hydrazone bonds, demonstrating its efficacy in antilymphoma properties for large B-cell lymphoma. DOX has also been released via pH control by Gao et al. where the star-shaped polymer micelles synthesized from poly (ε-caprolactone)/PEG effectively induced more tumor cell apotosis at pH 5.5 than the free drug itself.[192]"
    }, {
      "heading" : "7.2.3. Enzyme-Responsive Star-Shaped Polymers",
      "text" : "Byrne et al. synthesized well-defined star-shaped polypeptides with poly(g-benzyl-l-glutamate) (PBLG) arms from dendrimers of polypropylene imine by using g-benzyl-l-glutamate NCA initiators. Deprotecting these PBLG arms converted the stars into poly(l-glutamic acid) (PGA) star polypeptides. Different concentrations of drugs can be loaded into these star-shaped polymers depending on the length of the grafted chains as well as the number of PGA arms. Moreover, the PGA grafts, being polypeptidic in nature, were susceptible to the enzyme thermolysin, and bestowed enzyme-responsiveness and a means of controlled degradation to these star polypeptides[193] (Figure 17).\nMacromol. Rapid Commun. 2017, 1700410\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (18 of 25)"
    }, {
      "heading" : "7.2.4. Reduction-Responsive Star-Shaped Polymers",
      "text" : "A deviation from the above-mentioned methods involves the shedding of the shells of micelles of star-shaped polymers when placed in reductive environments. This was successfully displayed by Ren et al. when they developed star-shaped polymers based on PCL and PEG[194] (Figure 18). These micelles could first be internalized by tumors, following which the reductive environment would cause the shedding of the micelles’ shells, resulting in rapid drug release. This approach shows potential in intracellular drug delivery.\nIn a similar manner, redox stimulus responsive miktoarm star micelles synthesized from mPEG–SS–PMMA has been demonstrated to show rapid release of drug methotrexate in response to the reductive conditions, resulting in anitumor activity toward HeLa cells.[102] The drug was released in the presence of dithiothreitol (DTT) when the disulfide linkages in the polymers were broken and this observation adds as a new frontier in the cytoplasmic drug delivery."
    }, {
      "heading" : "7.2.5. Light-Responsive Star-Shaped Polymers",
      "text" : "Ability to control the release of drugs at targeted sites with controlled rate, from an external source is a novel advantage in the realm of gene delivery as it makes remote control possible. Light, especially, is an easily available and easily controllable source of external stimulus. Xue and co-workers have used porphyrin core, an organic compound with macrocycle conjugated structure, with poly(l-lysine) dendron arms to deliver pEGFP to 3T3 cells in vitro via the photodynamic therapy.[195] Porphyrins are well known for their photochemical internalization capabilities to release highly reactive oxygen species that induces an effective and selective destruction of diseased tissues.[196] However, its use has been dampened due to its selfquenching characteristics, hydrophobicity, and nonselectivity in in vivo applications. Star-shaped polymers with porphyrin cores have immense potential owing to their flexible architecture, controllable surface functionality, and low hydrodynamic radius. Dai et al., for example, have prepared star-shaped porphyrin-core poly(l-lactide)-b-poly (gluconamidoethyl methacrylate) block copolymers for targeted killing of diseased cells.[197] To improve this system, arginine was added onto the surface to improve the gene transfection efficiency, and was proven that this system was able to deliver both the hydrophobic DOC and MMP-9 plasmid simultaneously, escalating the nanomedicine delivery for cancer. Another star-shaped polymeric system that displays photodynamic capabilities was developed by Singh and co-workers where they used 4-arm PEG with biotin and coumarin chromophore to deliver chemotherapeutic drugs.[198] Coumarin can be activated to release the anticancer drug chlorambucil in a photocontrolled manner and the innate fluorescence properties offer the added advantage of photoguided therapy to deliver the drug to a more specific site (Figure 19).[199] Such synergistic behavior of single component organic polymer system demonstrates a strong potential platform for photoguided therapy."
    }, {
      "heading" : "7.2.6. Dual-Responsive Star-Shaped Polymers",
      "text" : "Among all the stimuli, temperature and pH are two important environmental factors in in vivo environment and also\nMacromol. Rapid Commun. 2017, 1700410\nFigure 16. Schematic representation of morphology changes in hybrid star PAA/PAH multilayer films. Reproduced with permission.[189] Copyright 2008, American Chemical Society.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (19 of 25)\ncan be designed easily in many applications.[25] Liu et al. synthesized an amphiphilic star block copolymer combining the temperature sensitive PNIPAAM and the pH sensitive PDMAEMA to form the hydrophilic arms of a star-shaped polymer with a hydrophobic core of PMMA. These stars formed stable micelles which had sizes in the range of 120 and 80 nm when they were loaded with drugs and unloaded, respectively. As both temperature and pH sensitive groups are present in the stars, they exhibited a pH-dependent thermoresponse, with LCSTs of 39.5, 36.6, and 32 °C, respectively, at pH 9, pH 7.4, and pH 5. When utilized in drug delivery at physiological conditions, the release profiles depended on both parameters, and they demonstrated pH-triggered accelerated drug release at fixed temperatures, and temperature-triggered accelerated drug release at fixed pH.[200] Xue et al. have used the same materials to deliver similar results, where their cationic 8-arm star polymers has thermo-, pH-, and ionic strength sensitivities.[201] Thus, these dual-responsive star-shaped polymers promise wide-ranging applications in drug delivery.\nAnother example of such thermo- and pH-responsive stars are those synthesized by Jackson and Fulton, which are watersoluble CCS prepared from cross-linking polymer chains containing amino and aldehyde functional groups to form dynamic imine bonds. The imine bond formation here is reversible, and its equilibrium is dependent on the pH of the environment, with high pH conditions favoring imine formation and low pH acidic environments doing the contrary. Release of any hydrophobic molecules that are complexed within the polymer cores can simply be triggered by altering the pH of the aqueous or physiological environment (Figure 20).[202] Moreover, the thermoresponsive cores allow these stars to reversibly switch between hydrophilic and hydrophobic character, which can also be utilized to trigger the release of the complexed hydrophobic molecules.[202]\nSchmalz et al. synthesized a dual-responsive star-shaped polymer based off poly(N,N-diethylaminoethyl methacrylate) (PDEA) to try to exhibit dual responsiveness to temperature and pH. The synthetic process was performed via ATRP in a “core-first” approach. PDEA stars respond to both temperature and pH variations, but the temperature-responsive behavior is independent of molecular weight and star architecture.[203]\nApart from the dual control of temperature and pH, crosslinked star polymers have also been designed to respond to both pH change and reduction environments. An example is that of Wang et al. where star-shaped polymers based\nMacromol. Rapid Commun. 2017, 1700410\nFigure 18. Schematic illustration of destabilization of star-shaped polymer micelle in reductive environment. Reproduced with permission.[195] Copyright 2011, The Royal Society of Chemistry.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (20 of 25)\non poly(l-glutamic acid)-poly(l-phenylalanine-co-l-cystine) (PLG-P(LP-co-LC)) was used to deliver DOX and trans-3,5,4′trihydroxystilbene (RES). In this architecture, the PLG interacts via strong electrostatic interaction with cationic DOX and the poly(l-phenylalanine) (PLP) interacts with the hydrophobic RES. The stable self-assembled structure dissociated with 10 × 10−3 m DTT and at low pH.[204]"
    }, {
      "heading" : "7.2.7. Star Polymer–Drug Conjugates",
      "text" : "It is well known that disulfides degrade in a fast rate in the cytoplasm because of the presence of reducing agents such as glutathione. Therefore, the conjugation of drugs onto star poly mers through disulfide linkages could be utilized to achieve the control release of the interested cargo. Following the cell internalization of the star polymer–drug conjugates and disassociation of the star polymer core, the drug release should be followed by efficient removal of the lower molecular weight star fragments from the body, which is expected to avoid the systemic toxic accumulation problems. In one recent study, Davisand co-workers designed star polymers with PEG grafts in the coronas and vinyl benzaldehyde (VBA) in the cores.[169] Due to the presence of the aldehyde functional groups in the cores, doxorubicin was able to be conjugated via a pH-sensitive imine bond and the pay loads of the star polymers were adjustable and can be controlled by manipulating the VBA composition in the cores. Interestingly, it showed that the imine bonds were easy to break at pH value of 5.5, which is comparable to the pH found in endosomes or lysozomes in cells. Further biological evaluation revealed that the doxorubicin-conjugated star polymers had a level of cytotoxicity\nand the results were comparable to that found for free doxorubicin, confirming the viability of using star polymer–drug conjugates for therapeutic applications.[169] Recently, Sumerlin and co-workers reported in a facile and efficient method for the attachment of anticancer drug methotrexate onto poly(N-(2-hydroxypropyl) methacrylamide) (PHPMA)-based star shape polymers (Figure 21).[205] MTX is a folic acid antagonist which has been widely used in the treatment of a number of cancers. The carboxylic acid functional group in MTX provides a straightforward approach for direct conjugation to the hydroxyl group of HPMA. To demon strate the versatility of the designed strategy, HPMA–MTX was used in the preparation of core cross-linked star polymer in a RAFT process. It showed that the drug could be directly polymerized without altering the integrity of the star polymer. Because of the nature of direct polymerization of drugconjugated monomers, the amount of drug in the star polymers could be tuned by controlling the degree of polymerization of the drug–monomer. By choosing a proper cross-linker in the core, the conjugated drugs in the star polymers could be more susceptible to release under specific conditions.[205]\nIn addition to the attachment of drug molecules, Liu et al. recently reported a multi-biomolecule conjugation onto β-CD-based star copolymers, including DOX, folic acid (FA), and gadolinium-tetraazacyclododecanetetraacetic acid (DOTAGd) moieties for integrated cancer cell-targeted drug delivery and magnetic resonance (MR) imaging contrast enhancement (Figure 22).[206] During the synthesis, asymmetrically functionalized β-CD consisting of 7 azide functionalities and 14 α-bromopropionate groups at the respective upper and lower rims of the rigid toroidal β-CD core, (N3)7-CD-(Br)14, was first prepared. The subsequent ATRP of HPMA, conjugated\nMacromol. Rapid Commun. 2017, 1700410\nFigure 20. Schematic illustrating the functioning of a dual-responsive CCS. Reproduced with permission.[203] Copyright 2011, Royal Society of Chemistry.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (21 of 25)\nwith DOX and FA, and click reaction with alkynyl-(DOTA-Gd) complex afforded the (DOTA-Gd)7-CD-(PHPMA-FA-DOX)14 star polymer. The resultant star polymers possess 7 DOTA-Gd complex moieties and 14 PHPMA arms which are covalently anchored with DOX and FA via acid-labile carbamate linkages and ester bonds, respectively. In vitro drug release investigation showed a highly pH-dependent release of DOX. In a time period of 42 h, the cumulative releases of DOX was 10%, 53%, and 89% conjugated DOX at pH 7.4, 5.0, and 4.0, respectively. Together with the targeting effect and enhanced T1 relaxivity, the integrated design of diagnostic and therapeutic functions of multifunctional pH-disintegrable star polymers augurs well for potential applications in the field of image-guided cancer chemotherapy.[206]"
    }, {
      "heading" : "7.3. In Vivo Studies of Star Polymers",
      "text" : "Many of the earlier described work have evaluated the utility of the polymers in vitro, investigation of these star polymers in vivo has been limited. The pharmacokinetics of a 64 kDa tritiated PEG-based star polymer after subcutaneous and\nMacromol. Rapid Commun. 2017, 1700410\nFigure 22. Schematic illustration for the fabrication of multifunctional micellar nanoparticles integrated with targeted drug delivery and magnetic resonance (MR) imaging contrast enhancement functions from β-CD-based star copolymers, (DOTA-Gd)7–CD–(PHPMA–FA–DOX)14, covalently conjugated with doxorubicin (DOX), folic acid (FA), and DOTA-Gd (Gd) moieties, and pH-induced DOX release via the cleavage of acid-labile carbamate linkages between DOX and HPMA arms. Reproduced with permission.[207] Copyright 2012, Elsevier B.V.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (22 of 25)\npulmonary administration in rats were evaluated.[207] Upon administration subcutaneously, there was almost complete bioavailability of the polymers as well as a similar organ biodistribution profile to the polymer after intravenous administration. From the results, it was noted that star polymers displayed similar pharmacokinetic behavior to PEGylated dendrimers. Another paper reports behavior of poly[(oligoethylene glycol) acrylate] (POEGA) star polymers synthesized via a versatile arm-first RAFT polymerization approach in vivo. Three different molecular weight (49, 64, and 94 kDa) POEGA star polymers were assessed in rats and nude mice bearing human MDA MB-231 tumors after intravenous administration.[208] The largest star polymer showed a longer plasma exposure time than the smaller star polymers due to different polymer biodegradation and urinary excretion rates. Tumor biodistribution was greatest for the longest circulating 94 kDa star. Biodegradable RAFT synthesized PDMAEMA stars was synthesized via chain extended in the presence of N,N-bis(acryloyl)cystamine and DMAEMA.[209] The star polymers were able to self-assemble with siRNA and form small uniform nanoparticle complexes. The star polymers appeared nontoxic to cells and treatment with star polymer–siRNA complexes resulted in uptake of siRNA into cells as well as a significant decrease in target gene mRNA and protein levels. In addition, delivery of clinically relevant amounts of siRNA complexed to the star polymer silenced target gene expression by 50% in an in vivo tumor setting. RAFT synthesized star polymers were designed to contain different lengths of cationic PDMAEMA side arms and varied amounts of POEGMA.[210] The star-POEGMA polymers formed polyplexes with siRNA. These polyplexes delivered siRNA with to pancreatic cancer cells to silence a gene (TUBB3/βIIItubulin) which is currently undruggable using chemical agents, and is involved in regulating tumor growth and metastases. The systemic administration of the polyplexes resulted in high accumulation of siRNA to orthotopic pancreatic tumors in mice and silenced βIII-tubulin expression by 80% at the gene and protein levels in pancreatic tumors. The same group has also studied the influence of the structure of star macromolecular ligands on the relaxivity of gadolinium contrast agents constructed as nanoparticle systems.[211] Further development could look at the precise control of biological cues in a star polymer and triggered release and breakdown of such structures in an in vivo system.[212]"
    }, {
      "heading" : "8. Conclusion",
      "text" : "As mentioned earlier, the improvements in the techniques and development of new methods for polymerization has been a great boon to the advancement of polymer engineering. One of the results of these developments is the introduction of complex star-shaped polymer architectures, which bring about a host of unique properties and applications. Upon modulating the starting materials compositions and conditions, these polymers are able to self-organize, leading to the formation of micellar aggregates, nanoparticles, and core–shell structures with properties that are different from the linear versions of themselves. These self-assembled structures have the added advantage of avoiding premature degradation by the host system before\nreaching the target site since the arms structure aggregates prevent the direct contact with the in vivo degradation mechanisms. Moreover, the polymer arms can be functionalized with different chemical groups to influence the response behavior, resulting in more controlled and targeted delivery of the drug carried. The polymers can also be made to vary in terms of morphology by the simple tweaking of arm lengths and chemical compositions, making the synthesis of various star-shaped polymers easily achievable without raising the manufacturing cost.\nFinally, since star-shaped polymers are still in the nascent stages of development, and because of the sheer diversity of macromolecules that can take on the star architectures (which is also made possible by the flexible synthesis and polymerization techniques), many structure–property relationships have yet to be fully established. Thus, it requires further exploration into the potential influence of the number of arms, their lengths, the functionalities of the blocks, arms and cores, and their self-assembly and stimuli-responsive properties, and how these correlate to their loading capacities and drug release profiles. The special architecture, together with the highly active functional group density puts star-shaped polymers in the prime position to be utilized for future developments in drug delivery.\nConflict of Interest The authors declare no conflict of interest.\nKeywords biomaterials, drug delivery, polymers\nReceived: June 20, 2017 Revised: June 28, 2017\nPublished online:\n[1] J. L. Schultz, E. S. Wilks, J. Chem. Inf. Model. 1998, 38, 85. [2] S. Cosson, M. Danial, J. R. Saint-Amans, J. J. Cooper-White,\nMacromol. Rapid Commun. 2017, 38, 1600780. [3] F. Hild, N. T. Nguyen, E. Deng, J. Katrib, G. Dimitrakis, P. L. Lau,\nD. J. Irvine, Macromol. Rapid Commun. 2016, 37, 1295. [4] K. Ma, Z. S. An, Macromol. Rapid Commun. 2016, 37, 1593. [5] R. d’Arcy, A. Gennari, R. Donno, N. Tirelli, Macromol. Rapid\nCommun. 2016, 37, 1918. [6] E. Ye, X. J. Loh, Aust. J. Chem. 2013, 66, 997. [7] J. G. Tirrell, M. J. Fournier, T. L. Mason, D. A. Tirrel, Chem. Eng.\nNews Arch. 1994, 72, 40. [8] A. W. Jackson, D. A. Fulton, Polym. Chem. 2013, 4, 31. [9] W. Xu, A. A. Steinschulte, F. A. Plamper, V. F. Korolovych,\nV. V. Tsukruk, Chem. Mater. 2016, 28, 975. [10] Y.-L. Wu, X. Chen, W. Wang, X. J. Loh, Macromol. Chem. Phys.\n2016, 217, 175. [11] S. S. Liow, Q. Dou, D. Kai, A. A. Karim, K. Zhang, F. Xu, X. J. Loh,\nACS Biomater. Sci. Eng. 2016, 2, 295. [12] X. J. Loh, J. Appl. Polym. Sci. 2013, 127, 2046. [13] X. J. Loh, J. Appl. Polym. Sci. 2013, 127, 992. [14] X. J. Loh, M.-H. Tsai, J. del Barrio, E. A. Appel, T.-C. Lee,\nO. A. Scherman, Polym. Chem. 2012, 3, 3180.\nMacromol. Rapid Commun. 2017, 1700410\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (23 of 25)\n[15] V. P. N. Nguyen, N. Kuo, X. J. Loh, Soft Matter 2011, 7, 2150. [16] X. J. Loh, V. P. N. Nguyen, N. Kuo, J. Li, J. Mater. Chem. 2011, 21,\n2246. [17] E. Ye, P. L. Chee, A. Prasad, X. Fang, C. Owh, V. J. J. Yeo, X. J. Loh,\nMater. Today 2014, 17, 194. [18] X. An, A. Zhu, H. Luo, H. Ke, H. Chen, Y. Zhao, ACS Nano\n2016. [19] Q. Yang, L. Li, W. Sun, Z. Zhou, Y. Huang, ACS Appl. Mater. Inter-\nfaces 2016, 8, 13251. [20] W. Lin, N. Yao, H. Li, S. Hanson, W. Han, C. Wang, L. Zhang, Poly-\nmers 2016, 8, 397. [21] X. Song, Y. Wen, J.-l. Zhu, F. Zhao, Z.-X. Zhang, J. Li,\nBiomacromole cules 2016, 17, 3957. [22] A. A. Hwang, J. Lu, F. Tamanoi, J. I. Zink, Small 2015, 11, 319. [23] S. S. Liow, Q. Dou, D. Kai, Z. Li, S. Sugiarto, C. Y. Yu, R. T. Kwok,\nX. Chen, Y. L. Wu, S. T. Ong, A. Kizhakeyil, N. K. Verma, B. Z. Tang, X. J. Loh, Small 2017, 13, 1603404. [24] Z. Li, D. Yuan, G. Jin, B. H. Tan, C. He, ACS Appl. Mater. Interfaces 2016, 8, 1842. [25] Z. Li, E. Ye, David, R. Lakshminarayanan, X. J. Loh, Small 2016, 35, 4782. [26] X. J. Loh, B. J. H. Yee, F. S. Chia, J. Biomed. Mater. Res., Part A 2012, 100, 2686. [27] X. J. Loh, W. Guerin, S. M. Guillaume, J. Mater. Chem. 2012, 22, 21249. [28] A. C. Fonseca, A. C. Serra, J. F. J. Coelho, EPMA J. 2015, 6, 22. [29] Z. Tang, L. Zhang, Y. Wang, D. Li, Z. Zhong, S. Zhou, Acta Bio-\nmater. 2016, 42, 232. [30] X. Zhou, Q. Zheng, C. Wang, J. Xu, J. Wu, T. B. Kirk, D. Ma,\nW. Xue, ACS Appl. Mater. Interfaces 2016, 8, 12609. [31] X. Fan, B. H. Tan, Z. Li, X. J. Loh, ACS Sustainable Chem. Eng.\n2017, 5, 1217. [32] Z. Li, B. H. Tan, T. Lin, C. He, Prog. Polym. Sci. 2016, 62, 22. [33] Z. Li, X. J. Loh, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol.\n2016, 9, e1429. [34] X. D. Chi, X. F. Ji, L. Shao, F. H. Huang, Macromol. Rapid Commun.\n2017, 38, 1600626. [35] H. Henke, O. Bruggemann, I. Teasdale, Macromol. Rapid Commun.\n2017, 38, 1600644. [36] R. Aksakal, M. Resmini, C. Becer, Polym. Chem. 2016, 7, 171. [37] S. Kikuchi, Y. Chen, E. Ichinohe, K. Kitano, S.-i. Sato, Q. Duan,\nX. Shen, T. Kakuchi, Macromolecules 2016, 49, 4828. [38] Y. Pan, P. Cai, M. Farmahini-Farahani, Y. Li, X. Hou, H. Xiao, Appl.\nSurf. Sci. 2016, 385, 333. [39] Y. Azuma, T. Terashima, M. Sawamoto, Macromolecules 2017, 50,\n587. [40] Y. X. Chen, Z. Y. Yang, C. Liu, C. W. Wang, S. X. Zhao, J. Yang,\nH. F. Sun, Z. P. Zhang, D. L. Kong, C. X. Song, Int. J. Nanomed. 2013, 8, 4315. [41] J. M. Ren, T. G. McKenzie, Q. Fu, E. H. Wong, J. Xu, Z. An, S. Shanmugam, T. P. Davis, C. Boyer, G. G. Qiao, Chem. Rev. 2016, 116, 6743. [42] A. P. Narrainen, S. Pascual, D. M. Haddleton, J. Polym. Sci., Part A: Polym. Chem. 2002, 40, 439. [43] C. F. Huang, J. Aimi, K. Y. Lai, Macromol. Rapid Commun. 2017, 38, 1600607. [44] X. Y. Zhang, D. M. Liu, X. H. Lv, M. Sun, X. L. Sun, W. M. Wan, Macromol. Rapid Commun. 2016, 37, 1735. [45] D. Kuckling, A. Wycisk, J. Polym. Sci., Part A: Polym. Chem. 2013, 51, 2980. [46] G. R. J. Artus, S. Olveira, D. Patra, S. Seeger, Macromol. Rapid Commun. 2017, 38, 1600616. [47] H. Henke, S. Posch, O. Bruggemann, I. Teasdale, Macromol. Rapid Commun. 2016, 37, 769.\n[48] S. Nagarajan, B. S. R. Reddy, J. Tsibouklis, Eur. Polym. J. 2012, 48, 1357. [49] W. Tao, X. W. Zeng, T. Liu, Z. Y. Wang, Q. Q. Xiong, C. P. Ouyang, L. Q. Huang, L. Mei, Acta Biomater. 2013, 9, 8910. [50] M. Jesberger, L. Barner, M. H. Stenzel, E. Malmstrom, T. P. Davis, C. Barner-Kowollik, J. Polym. Sci., Part A: Polym. Chem. 2003, 41, 3847. [51] G. Kreutzer, C. Ternat, T. Q. Nguyen, C. J. G. Plummer, J. A. E. Manson, V. Castelletto, I. W. Hamley, F. Sun, S. S. Sheiko, A. Herrmann, L. Ouali, H. Sommer, W. Fieber, M. I. Velazco, H. A. Klok, Macromolecules 2006, 39, 4507. [52] X. J. Hao, C. Nilsson, M. Jesberger, M. H. Stenzel, E. Malmstrom, T. P. Davis, E. Ostmark, C. Barner-Kowollik, J. Polym. Sci., Part A: Polym. Chem. 2004, 42, 5877. [53] J. L. Hedrick, M. Trollsas, C. J. Hawker, B. Atthoff, H. Claesson, A. Heise, R. D. Miller, D. Mecerreyes, R. Jerome, P. Dubois, Macromolecules 1998, 31, 8691. [54] D. M. Haddleton, K. Ohno, Biomacromolecules 2000, 1, 152. [55] M. H. Stenzel-Rosenbaum, T. P. Davis, V. K. Chen, A. G. Fane,\nMacromolecules 2001, 34, 5433. [56] H. F. Gao, K. Matyjaszewski, Macromolecules 2008, 41, 1118. [57] S. Angot, N. Ayres, S. A. F. Bon, D. M. Haddleton, Macromolecules\n2001, 34, 768. [58] L. Barner, C. Li, X. J. Hao, M. H. Stenzel, C. Barner-Kowollik,\nT. P. Davis, J. Polym. Sci., Part A: Polym. Chem. 2004, 42, 5067. [59] S. Muthukrishnan, F. Plamper, H. Mori, A. H. E. Muller,\nMacromole cules 2005, 38, 10631. [60] K. Ohno, B. Wong, D. M. Haddleton, J. Polym. Sci., Part A: Polym.\nChem. 2001, 39, 2206. [61] Q. Zhang, G. Z. Li, C. R. Becer, D. M. Haddleton, Chem. Commun.\n2012, 48, 8063. [62] J. L. Bender, P. S. Corbin, C. L. Fraser, D. H. Metcalf,\nF. S. Richardson, E. L. Thomas, A. M. Urbas, J. Am. Chem. Soc. 2002, 124, 8526. [63] O. Altintas, A. P. Vogt, C. Barner-Kowollik, U. Tunca, Polym. Chem. 2012, 3, 34. [64] J. Zhu, Y. Y. Liu, L. Q. Xiao, P. Zhou, Macromol. Chem. Phys. 2016, 217, 773. [65] W.-M. Wan, A. W. Baggett, F. Cheng, H. Lin, S.-Y. Liu, F. Jäkle, Chem. Commun. 2016, 52, 13616. [66] F. Khelifa, S. Ershov, Y. Habibi, R. Snyders, P. Dubois, Chem. Rev. 2016, 116, 3975. [67] J. Merna, P. Vlček, V. Volkis, J. Michl, Chem. Rev. 2016, 116, 771. [68] S. Beyazit, B. T. S. Bui, K. Haupt, C. Gonzato, Prog. Polym. Sci.\n2016, 62, 1. [69] M. Semsarilar, S. Perrier, Nat. Chem. 2010, 2, 811. [70] J. Jennings, G. He, S. M. Howdle, P. B. Zetterlund, Chem. Soc. Rev.\n2016, 45, 5055. [71] Z. Zhang, P. Zhang, Y. Wang, W. Zhang, Polym. Chem. 2016, 7, 3950. [72] Z. Li, D. Yuan, X. Fan, B. H. Tan, C. He, Langmuir 2015, 31, 2321. [73] U. U. Ozkose, C. Altinkok, O. Yilmaz, O. Alpturk, M. A. Tasdelen,\nEur. Polym. J. 2017, 88, 586. [74] M. Bednarek, Prog. Polym. Sci. 2016, 58, 27. [75] Z. Li, H. Yin, Z. Zhang, K. L. Liu, J. Li, Biomacromolecules 2012, 13,\n3162. [76] Z. Li, P. L. Chee, C. Owh, R. Lakshminarayanan, X. J. Loh, RSC\nAdv. 2016, 6, 28947. [77] J. Collins, S. J. Wallis, A. Simula, M. R. Whittaker, M. P. McIntosh,\nP. Wilson, T. P. Davis, D. M. Haddleton, K. Kempe, Macromol. Rapid Commun. 2017, 38, 1600534. [78] M. Fantin, F. Lorandi, A. A. Isse, A. Gennaro, Macromol. Rapid Commun. 2016, 37, 1318. [79] X. W. Jiang, L. F. Zhang, Z. P. Cheng, X. L. Zhu, Macromol. Rapid Commun. 2016, 37, 1337.\nMacromol. Rapid Commun. 2017, 1700410\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (24 of 25)\n[80] D. C. McLeod, N. V. Tsarevsky, Macromol. Rapid Commun. 2016, 37, 1694. [81] Y. Sha, D. L. Qi, S. C. Luo, X. H. Sun, X. L. Wang, G. Xue, D. S. Zhou, Macromol. Rapid Commun. 2017, 38, 1600568. [82] K. E. Styan, C. D. Easton, L. G. Weaver, L. Meagher, Macromol. Rapid Commun. 2016, 37, 1079. [83] L. Wu, U. Glebe, A. Boker, Macromol. Rapid Commun. 2017, 38, 1600475. [84] J. Xia, X. Zhang, K. Matyjaszewski, Macromolecules 1999, 32, 4482. [85] P. Chmielarz, S. Park, A. Sobkowiak, K. Matyjaszewski, Polymer\n2016, 88, 36. [86] Y. M. Li, B. Xu, T. Bai, W. G. Liu, Biomaterials 2015, 55, 12. [87] X. J. Loh, Z.-X. Zhang, K. Y. Mya, Y.-l. Wu, C. B. He, J. Li, J. Mater.\nChem. 2010, 20, 10634. [88] Y. Y. Yang, X. Wang, Y. Hu, H. Hu, D. C. Wu, F. J. Xu, ACS Appl.\nMater. Interfaces 2014, 6, 1044. [89] L. N. Li, Y. Wang, F. Ji, Y. Wen, J. J. Li, B. G. Yang, F. L. Yao, J. Bio-\nmater. Sci., Polym. Ed. 2014, 25, 1641. [90] X. H. Dai, Z. M. Wang, Y. F. Huang, J. M. Pan, Y. S. Yan, D. M. Liu,\nL. Sun, RSC Adv. 2014, 4, 42486. [91] S. Li, H. S. Chung, A. Simakova, Z. Wang, S. Park, L. Fu,\nD. Cohen-Karni, S. Averick, K. Matyjaszewski, Biomacromolecules 2017, 18, 475. [92] H. Gao, K. Matyjaszewski, Macromol. Symp. 2010, 291–292, 12. [93] K. Matyjaszewski, H. Dong, W. Jakubowski, J. Pietrasik,\nA. Kusumo, Langmuir 2007, 23, 4528. [94] D. J. Keddie, Chem. Soc. Rev. 2014, 43, 496. [95] H. T. Ho, M. Le Bohec, J. Fremaux, S. Pioge, N. Casse, L. Fontaine,\nS. Pascual, Macromol. Rapid Commun. 2017, 38, 1600641. [96] L. Peng, Z. Y. Li, X. H. Li, H. Xue, W. D. Zhang, G. J. Chen,\nMacromol. Rapid Commun. 2017, 38, 1600548. [97] W. T. Xue, J. Wang, M. Wen, G. J. Chen, W. D. Zhang, Macromol.\nRapid Commun. 2017, 38, 1600733. [98] C. Boyer, V. Bulmus, T. P. Davis, V. Ladmiral, J. Liu, S. Perrier,\nChem. Rev. 2009, 109, 5402. [99] R. T. Mayadunne, J. Jeffery, G. Moad, E. Rizzardo, Macromolecules\n2003, 36, 1505. [100] C. Zhang, Y. Zhou, Q. Liu, S. Li, S. B. Perrier, Y. Zhao, Macro-\nmolecules 2011, 44, 2034. [101] T. G. Wright, W. Weber, H. Pfukwa, H. Pasch, Macromol. Chem.\nPhys. 2015, 216, 1562. [102] Q. H. Zhou, J. Lin, L. D. Li, L. Shang, Colloid Polym. Sci. 2015, 293,\n2291. [103] T. G. McKenzie, E. H. H. Wong, Q. Fu, A. Sulistio, D. E. Dunstan,\nG. G. Qiao, ACS Macro Lett. 2015, 4, 1012. [104] O. Garcia-Valdez, R. Ledezma-Rodriguez, R. Torres-Lubian, L. Yate,\nE. Saldivar-Guerra, R. F. Ziolo, Macromol. Chem. Phys. 2016, 217, 2099. [105] N. B. Kannan, B. H. Lessard, Macromol. React. Eng. 2016, 10, 600. [106] B. King, B. H. Lessard, Macromol. React. Eng. 2017, 11, 1600073. [107] D. D. Ozcam, F. Teymour, Macromol. React. Eng. 2017, 11, 1600042. [108] R. Schroot, T. Schlotthauer, M. Jager, U. S. Schubert, Macromol. Chem. Phys. 2017, 218, 1600534. [109] Y. N. Zhou, Z. H. Luo, Macromol. React. Eng. 2016, 10, 516. [110] D. Le, T. N. Phan, L. Autissier, L. Charles, D. Gigmes, Polym. Chem. 2016, 7, 1659. [111] T. Junkers, C. Barner-Kowollik, J. Lalevée, in RSC Polymer Chemistry Series (Eds: D. Gigmes), Royal Society of Chemistry, London 2016. [112] T. N. Phan, A. Ferrand, L. Liénafa, M. Rollet, S. Maria, R. Bouchet, D. Gigmes, Polym. Chem. 2016, 7, 6901. [113] A. Darabi, O. García-Valdez, P. Champagne, M. F. Cunningham,\nMacromol. React. Eng. 2016, 10, 82.\n[114] N. Alkayal, H. Durmaz, U. Tunca, N. Hadjichristidis, Polym. Chem. 2016, 7, 2986. [115] C. J. Hawker, A. W. Bosman, E. Harth, Chem. Rev. 2001, 101, 3661. [116] S. Abrol, P. A. Kambouris, M. G. Looney, D. H. Solomon, Macromol. Rapid Commun. 1997, 18, 755. [117] A. J. Pasquale, T. E. Long, J. Polym. Sci., Part A: Polym. Chem. 2001, 39, 216. [118] T. Tsoukatos, S. Pispas, N. Hadjichristidis, J. Polym. Sci., Part A: Polym. Chem. 2001, 39, 320. [119] C.-H. Lu, J.-H. Wang, F.-C. Chang, S.-W. Kuo, Macromol. Chem. Phys. 2010, 211, 1339. [120] R. J. I. Knoop, M. de Geus, G. J. M. Habraken, C. E. Koning, H. Menzel, A. Heise, Macromolecules 2010, 43, 4126. [121] Y. Satoh, K. Miyachi, H. Matsuno, T. Isono, K. Tajima, T. Kakuchi, T. Satoh, Macromolecules 2016, 49, 499. [122] S. Cui, X. Pan, H. Gebru, X. Wang, J. Liu, J. Liu, Z. Li, K. Guo, J. Mater. Chem. B 2017, 5, 679. [123] Z. Li, J. Yang, X. J. Loh, NPG Asia Mater. 2016, 8, e265. [124] Z. Li, B. H. Tan, Mater. Sci. Eng., C 2014, 45, 620. [125] J. T. Wiltshire, G. G. Qiao, Macromolecules 2006, 39, 4282. [126] A. Mielanczyk, M. Skonieczna, K. Bernaczek, D. Neugebauer, RSC Adv. 2014, 4, 31904. [127] C. Yang, S. Q. Liu, S. Venkataraman, S. J. Gao, X. Y. Ke, X. T. Chia,\nJ. L. Hedrick, Y. Y. Yang, J. Controlled Release 2015, 208, 93. [128] Z. Wu, H. Liang, J. Lu, Macromolecules 2010, 43, 5699. [129] W. Zhang, W. Zhang, N. Zhou, J. Zhu, Z. Cheng, X. Zhu, J. Polym.\nSci., Part A: Polym. Chem. 2009, 47, 6304. [130] K. Ranganathan, R. Deng, R. K. Kainthan, C. Wu, D. E. Brooks,\nJ. N. Kizhakkedathu, Macromolecules 2008, 41, 4226. [131] J. Han, D. Zhu, C. Gao, Polym. Chem. 2013, 4, 542. [132] T. Isono, Y. Kondo, I. Otsuka, Y. Nishiyama, R. Borsali, T. Kakuchi,\nT. Satoh, Macromolecules 2013, 46, 8509. [133] M. Olvera de La Cruz, I. C. Sanchez, Macromolecules 1986, 19, 2501. [134] F. Wang, T. K. Bronich, A. V. Kabanov, R. D. Rauh, J. Roovers, Bioconjugate Chem. 2005, 16, 397. [135] Z. Li, Z. Zhang, K. L. Liu, X. Ni, J. Li, Biomacromolecules 2012, 13, 3977. [136] Z. Li, B. H. Tan, G. Jin, K. Li, C. He, Polym. Chem. 2014, 5, 6740. [137] X. Fan, Z. Wang, D. Yuan, Y. Sun, Z. Li, C. He, Polym. Chem. 2014, 5, 4069. [138] C. Clasen, J. Plog, W.-M. Kulicke, M. Owens, C. Macosko, L. Scriven, M. Verani, G. H. McKinley, J. Rheol. 2006, 50, 849. [139] Y.-L. Zhao, Q. Cai, J. Jiang, X.-T. Shuai, J.-Z. Bei, C.-F. Chen, F. Xi, Polymer 2002, 43, 5819. [140] S. H. Lee, S. Hyun Kim, Y. K. Han, Y. H. Kim, J. Polym. Sci., Part A: Polym. Chem. 2001, 39, 973. [141] D. S. Pearson, E. Helfand, Macromolecules 1984, 17, 888. [142] M. H. Xie, J. Ge, Y. M. Xue, Y. Z. Du, B. Lei, P. X. Ma, J. Mech. Behav. Biomed. Mater. 2015, 51, 163. [143] Z. Ge, Y. Cai, J. Yin, Z. Zhu, J. Rao, S. Liu, Langmuir 2007, 23, 1114. [144] J. Wang, F. Zhang, W. P. Tsang, C. Wan, C. Wu, Biomaterials 2017, 120, 11. [145] Z.-X. Zhang, K. L. Liu, J. Li, Angew. Chem., Int. Ed. 2013, 52, 6180. [146] A. A. Karim, Q. Dou, Z. Li, X. J. Loh, Chem. - Asian J. 2016, 11, 1300. [147] X. Fan, J. Y. Chung, Y. X. Lim, Z. Li, X. J. Loh, ACS Appl. Mater. Interfaces 2016, 8, 33351. [148] R. Satchi-Fainaro, R. Duncan, Polymer Therapeutics II: Polymers as\nDrugs, Conjugates and Gene Delivery Sytems, Springer Science & Business Media, New York, USA 2006.\nMacromol. Rapid Commun. 2017, 1700410\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700410 (25 of 25)\n[149] K. Knop, D. Pretzel, A. Urbanek, T. Rudolph, D. H. Scharf, A. Schallon, M. Wagner, S. Schubert, M. Kiehntopf, A. A. Brakhage, F. H. Schacher, U. S. Schubert, Biomacromolecules 2013, 14, 2536. [150] F. A. Plamper, H. Becker, M. Lanzendörfer, M. Patel, A. Wittemann, M. Ballauff, A. H. Müller, Macromol. Chem. Phys. 2005, 206, 1813. [151] P. Alonso-Cristobal, M. Laurenti, F. J. Sanchez-Muniz, E. Lopez-Cabarcos, J. Rubio-Retama, Polymer 2012, 53, 4569. [152] T. Liu, W. Xue, B. Ke, M. Q. Xie, D. Ma, Biomaterials 2014, 35, 3865. [153] D. Ma, H. B. Zhang, Y. Y. Chen, J. T. Lin, L. M. Zhang, J. Colloid Interface Sci. 2013, 405, 305. [154] P. J. Photos, L. Bacakova, B. Discher, F. S. Bates, D. E. Discher, J. Controlled Release 2003, 90, 323. [155] Y. Matsumura, H. Maeda, Cancer Res. 1986, 46, 6387. [156] J. Kamada, K. Koynov, C. Corten, A. Juhari, J. A. Yoon, M. W. Urban,\nA. C. Balazs, K. Matyjaszewski, Macromolecules 2010, 43, 4133. [157] H. Xu, J. Xu, X. Jiang, Z. Zhu, J. Rao, J. Yin, T. Wu, H. Liu, S. Liu,\nChem. Mater. 2007, 19, 2489. [158] X. Fan, Z. Li, X. J. Loh, Polym. Chem. 2016, 7, 5898. [159] R. S. Navath, B. Wang, S. Kannan, R. Romero, R. M. Kannan,\nJ. Controlled Release 2010, 142, 447. [160] A. M. Alhoranta, J. K. Lehtinen, A. O. Urtti, S. J. Butcher,\nV. O. Aseyev, H. J. Tenhu, Biomacromolecules 2011, 12, 3213. [161] S. Banskota, P. Yousefpour, A. Chilkoti, Macromol. Biosci. 2017, 17,\n1600361. [162] M. Y. Liu, P. Gao, Q. Wan, F. J. Deng, Y. Wei, X. Y. Zhang,\nMacromol. Rapid Commun. 2017, 38, 1600575. [163] A. Polomska, J. C. Leroux, D. Brambilla, Macromol. Biosci. 2017,\n17, 1600228. [164] T. Rhim, K. Y. Lee, Macromol. Res. 2016, 24, 577. [165] R. Suntornnond, J. An, C. K. Chua, Macromol. Mater. Eng. 2017,\n302, 1600266. [166] T. Thambi, V. H. G. Phan, D. S. Lee, Macromol. Rapid Commun.\n2016, 37, 1881. [167] O. Zagorodko, J. J. Arroyo-Crespo, V. J. Nebot, M. J. Vicent,\nMacromol. Biosci. 2017, 17, 1600316. [168] P.-F. Gou, W.-P. Zhu, Z.-Q. Shen, Biomacromolecules 2010, 11, 934. [169] J. Liu, H. Duong, M. R. Whittaker, T. P. Davis, C. Boyer, Macromol.\nRapid Commun. 2012, 33, 760. [170] H. Wei, X. Zhang, C. Cheng, S.-X. Cheng, R.-X. Zhuo, Biomaterials\n2007, 28, 99. [171] T. Ooya, J. Lee, K. Park, J. Controlled Release 2003, 93, 121. [172] J. Cheng, J.-X. Ding, Y.-C. Wang, J. Wang, Polymer 2008, 49, 4784. [173] J. Deng, N. Li, K. Mai, C. Yang, L. Yan, L.-M. Zhang, J. Mater.\nChem. 2011, 21, 5273. [174] X. Fan, S. Jiang, Z. Li, X. J. Loh, Mater. Sci. Eng., C 2017, 73, 275. [175] B. Jeong, Y. K. Choi, Y. H. Bae, G. Zentner, S. W. Kim, J. Controlled\nRelease 1999, 62, 109. [176] Z. Li, J. Li, J. Phys. Chem. B 2013, 117, 14763. [177] B. H. Tan, J. K. Muiruri, Z. Li, C. He, ACS Sustainable Chem. Eng.\n2016, 4, 5370. [178] J. T. Wiltshire, G. G. Qiao, Macromolecules 2006, 39, 9018. [179] L. Kilian, Z. H. Wang, T. E. Long, J. Polym. Sci., Part A: Polym.\nChem. 2003, 41, 3083. [180] E. Themistou, C. S. Patrickios, Macromolecules 2004, 37, 6734. [181] H. Gao, N. V. Tsarevsky, K. Matyjaszewski, Macromolecules 2005,\n38, 5995. [182] W. Wu, J. Liu, S. Cao, H. Tan, J. Li, F. Xu, X. Zhang, Int. J. Pharm.\n2011, 416, 104. [183] Y. Zhang, H. Liu, H. Dong, C. Li, S. Liu, J. Polym. Sci., Part A:\nPolym. Chem. 2009, 47, 1636.\n[184] W.-Q. Chen, H. Wei, S.-L. Li, J. Feng, J. Nie, X.-Z. Zhang, R.-X. Zhuo, Polymer 2008, 49, 3965. [185] H. J. Zhang, Q. Yan, Y. Kang, L. L. Zhou, H. Zhou, J. Y. Yuan, S. Z. Wu, Polymer 2012, 53, 3719. [186] O. G. Schramm, M. A. Meier, R. Hoogenboom, H. P. van Erp, J.-F. Gohy, U. S. Schubert, Soft Matter 2009, 5, 1662. [187] D. Kul, L. M. Van Renterghem, M. A. Meier, S. Strandman, H. Tenhu, S. S. Yilmaz, U. S. Schubert, F. E. Du Prez, J. Polym. Sci., Part A: Polym. Chem. 2008, 46, 650. [188] L. A. Connal, Q. Li, J. F. Quinn, E. Tjipto, F. Caruso, G. G. Qiao, Macromolecules 2008, 41, 2620. [189] B.-S. Kim, H. Gao, A. A. Argun, K. Matyjaszewski, P. T. Hammond, Macromolecules 2008, 42, 368. [190] M.-C. Jones, M. Ranger, J.-C. Leroux, Bioconjugate Chem. 2003, 14, 774. [191] O. Lidicky, O. Janouskova, J. Strohalm, M. Alam, P. Klener, T. Etrych, Molecules 2015, 20, 19849. [192] X. Gao, B. L. Wang, X. W. Wei, W. Rao, F. Ai, F. Zhao, K. Men, B. W. Yang, X. Y. Liu, M. J. Huang, M. L. Gou, Z. Y. Qian, N. Huang, Y. Q. Wei, Int. J. Nanomed. 2013, 8, 971. [193] M. Byrne, P. D. Thornton, S.-A. Cryan, A. Heise, Polym. Chem. 2012, 3, 2825. [194] T.-B. Ren, Y. Feng, Z.-H. Zhang, L. Li, Y.-Y. Li, Soft Matter 2011, 7, 2329. [195] D. Ma, Q. M. Lin, L. M. Zhang, Y. Y. Liang, W. Xue, Biomaterials 2014, 35, 4357. [196] J. W. Snyder, W. R. Greco, D. A. Bellnier, L. Vaughan, B. W. Henderson, Cancer Res. 2003, 63, 8126. [197] X. H. Dai, Z. M. Wang, W. Liu, C. M. Dong, J. M. Pan, S. S. Yuan, Y. S. Yan, D. M. Liu, L. Sun, Colloid Polym. Sci. 2014, 292, 2111. [198] M. Gangopadhyay, T. Singh, K. K. Behara, S. Karwa, S. K. Ghosh, N. D. P. Singh, Photochem. Photobiol. Sci. 2015, 14, 1329. [199] Y. Zhao, Macromolecules 2012, 45, 3647. [200] Y. Liu, X. Cao, M. Luo, Z. Le, W. Xu, J. Colloid Interface Sci. 2009, 329, 244. [201] Y. Xue, D. F. Wei, A. N. Zheng, Y. Guan, H. N. Xiao, J. Macromol. Sci., Part A: Pure Appl. Chem. 2014, 51, 898. [202] A. W. Jackson, D. A. Fulton, Chem. Commun. 2011, 47, 6807. [203] A. Schmalz, M. Hanisch, H. Schmalz, A. H. E. Müller, Polymer 2010, 51, 1213. [204] W. L. Wang, L. Zhang, M. T. Liu, Y. Le, S. S. Lv, J. X. Wang, J. F. Chen, RSC Adv. 2016, 6, 6368. [205] B. S. Tucker, S. G. Getchell, M. R. Hill, B. S. Sumerlin, Polym.\nChem. 2015, 6, 4258. [206] T. Liu, X. Li, Y. Qian, X. Hu, S. Liu, Biomaterials 2012, 33, 2521. [207] S. Y. Khor, J. Hu, V. M. McLeod, J. F. Quinn, C. J. H. Porter,\nM. R. Whittaker, L. M. Kaminskas, T. P. Davis, J. Pharm. Sci. 2016, 105, 293.\n[208] S. Y. Khor, J. Hu, V. M. McLeod, J. F. Quinn, M. Williamson, C. J. H. Porter, M. R. Whittaker, L. M. Kaminskas, T. P. Davis, Nanomedicine 2015, 11, 2099. [209] C. Boyer, J. Teo, P. Phillips, R. B. Erlich, S. Sagnella, G. Sharbeen, T. Dwarte, H. T. T. Duong, D. Goldstein, T. P. Davis, M. Kavallaris, J. McCarroll, Mol. Pharmaceutics 2013, 10, 2435. [210] J. Teo, J. A. McCarroll, C. Boyer, J. Youkhana, S. M. Sagnella, H. T. T. Duong, J. Liu, G. Sharbeen, D. Goldstein, T. P. Davis, M. Kavallaris, P. A. Phillips, Biomacromolecules 2016, 17, 2337. [211] Y. Li, S. Laurent, L. Esser, L. V. Elst, R. N. Muller, A. B. Lowe, C. Boyer, T. P. Davis, Polym. Chem. 2014, 5, 2592. [212] J. F. Quinn, M. R. Whittaker, T. P. Davis, Polym. Chem. 2017, 8, 97.\nMacromol. Rapid Commun. 2017, 1700410"
    } ],
    "references" : [ {
      "title" : "Polym",
      "author" : [ "X.J. Loh", "J. Appl" ],
      "venue" : "Sci. 2013, 127,",
      "citeRegEx" : "12",
      "shortCiteRegEx" : null,
      "year" : 2046
    }, {
      "title" : "Chem",
      "author" : [ "X.J. Loh", "V.P.N. Nguyen", "N. Kuo", "J. Li", "J. Mater" ],
      "venue" : "2011, 21,",
      "citeRegEx" : "16",
      "shortCiteRegEx" : null,
      "year" : 2246
    }, {
      "title" : "Mater",
      "author" : [ "Z. Li", "D. Yuan", "G. Jin", "B.H. Tan", "C. He", "ACS Appl" ],
      "venue" : "Interfaces 2016, 8,",
      "citeRegEx" : "24",
      "shortCiteRegEx" : null,
      "year" : 1842
    }, {
      "title" : "Mater",
      "author" : [ "X.J. Loh", "B.J.H. Yee", "F.S. Chia", "J. Biomed" ],
      "venue" : "Res., Part A 2012, 100,",
      "citeRegEx" : "26",
      "shortCiteRegEx" : null,
      "year" : 2686
    }, {
      "title" : "Eng",
      "author" : [ "X. Fan", "B.H. Tan", "Z. Li", "X.J. Loh", "ACS Sustainable Chem" ],
      "venue" : "2017, 5,",
      "citeRegEx" : "31",
      "shortCiteRegEx" : null,
      "year" : 1217
    }, {
      "title" : "Mater",
      "author" : [ "Y.Y. Yang", "X. Wang", "Y. Hu", "H. Hu", "D.C. Wu", "F.J. Xu", "ACS Appl" ],
      "venue" : "Interfaces 2014, 6,",
      "citeRegEx" : "88",
      "shortCiteRegEx" : null,
      "year" : 1044
    }, {
      "title" : "Lalevée, in RSC Polymer Chemistry Series (Eds: D",
      "author" : [ "T. Junkers", "J.C. Barner-Kowollik" ],
      "venue" : "Gigmes), Royal Society of Chemistry,",
      "citeRegEx" : "111",
      "shortCiteRegEx" : "111",
      "year" : 2016
    }, {
      "title" : "Polymer Therapeutics II: Polymers as Drugs, Conjugates and Gene Delivery Sytems, Springer Science & Business Media",
      "author" : [ "R. Satchi-Fainaro", "R. Duncan" ],
      "venue" : "Macromol. Rapid Commun",
      "citeRegEx" : "148",
      "shortCiteRegEx" : "148",
      "year" : 2006
    } ],
    "referenceMentions" : [ {
      "referenceID" : 5,
      "context" : "In a similar approach, POSS core and eight disulfide-linked PDMAEMA with different molecular weights were synthesized (Figure 3).[88] In this work, vinyl-POSS was modified to be octasubstituted amine-terminated POSS by click reaction, followed by an arm extension reaction with succinic anhydride to generate eight carboxyl acid groups.",
      "startOffset" : 129,
      "endOffset" : 133
    }, {
      "referenceID" : 5,
      "context" : "Adapted with permission.[88] Copyright 2014, American Chemical Society.",
      "startOffset" : 24,
      "endOffset" : 28
    }, {
      "referenceID" : 6,
      "context" : "[110] NMRP then functions on the basis of the persistent radical effect (PRE), observable in some radical systems where the formation of one product is highly favored because of the stability of one of the radical species, nitroxide.[111,112] A critical point to note is that the coupling between these persistent radicals is reversible, hence, the persistent radicals still form a majority even as their concentration increases over an extended period of time.",
      "startOffset" : 233,
      "endOffset" : 242
    }, {
      "referenceID" : 7,
      "context" : "Thus, the composition of the core blocks can influence the efficacy of drug loading and drug release behaviors.[148] It also has to be noted that the compatibility between the drugs to be loaded and the micelle core-forming blocks is one of the crucial factors that should be accounted for when designing the star-shaped polymers.",
      "startOffset" : 111,
      "endOffset" : 116
    }, {
      "referenceID" : 4,
      "context" : "For instance, similar to PLA, PCL is also generally considered to be a biocompatible and biodegradable (although it takes some time) polymer[31,137,174,176,177] and this is incorporated into the arms of star-shaped polymers by using alkyl halide functionalized PCL chains in the synthesis process.",
      "startOffset" : 140,
      "endOffset" : 160
    } ],
    "year" : 2017,
    "abstractText" : "Prof. D.-P. Yang College of Chemical Engineering & Materials Science Quanzhou Normal University Quanzhou 362000, China M. N. N. L. Oo School of Chemical and Biomedical Engineering Nanyang Technological University 62 Nanyang Drive Singapore, Singapore 637459, Singapore Prof. G. R. Deen Soft Materials Laboratory Natural Sciences and Science Education National Institute of Education Nanyang Technological University Singapore 637459, Singapore Dr. Z. Li, Prof. X. J. Loh Institute of Materials Research and Engineering (IMRE) A*STAR, 2 Fusionopolis Way, Innovis, #08-03 Singapore 138634, Singapore E-mail: lizb@imre.a-star.edu.sg; lohxj@imre.a-star.edu.sg Prof. X. J. Loh Department of Materials Science and Engineering National University of Singapore 9 Engineering Drive 1, Singapore 117576, Singapore",
    "creator" : "Adobe InDesign CS6 (Macintosh)"
  }
}